Document:

Exhibit 4.10

 

 

	SOLICITATION/CONTRACT/ORDER FOR
        COMMERCIAL ITEMS

        OFFEROR TO COMPLETE BLOCKS 12,
        17, & 30
	1. REQUISITION NUMBER

         

        N/A
	PAGE
    1 OF 1
	2. CONTRACT NO.

         

            V797D-30190
	3. AWARD/EFFECTIVE DATE

         

            06/15/2013
	4. ORDER NO.    MODIFICATION NO.

         

        N/A
	5. SOLICITATION NO.

         

        RFP-797-FSS-99-0025-R7
	6. SOLICITATION ISSUE DATE

        4/22/2011

	7. FOR SOLICITATION

          INFORMATION CALL:
	a. NAME:

        FEDERAL SUPPLY SCHEDULE HELPDESK
	 	b. TELEPHONE NO. (No Collect Calls)

        (708) 786-7737
	8. OFFER DUE DATE/LOCAL TIME:

        N/A 

	9. ISSUED BY 	CODE	 	 	10. THIS ACQUISITION IS

        x UNRESTRICTED
        OR

         

        See Page 4 of the Read Me First document for NAICS codes
        and size standards under this solicitation.
	 

        x SET
        ASIDE FOR: (Total set-aside for SINs A-13a and A-13c only)

        x SMALL
        BUSINESS

         ̈  HUBZONE
        SMALL BUSINESS
	See Clause A-FSS-31

         

         

         ̈    EMERGING
        SMALL BUSINESS

	 

        VA National Acquisition Center

        Federal Supply Schedule Service 001AL-A2-2

        PO Box 76, Bldg 37

        Hines, IL 60141

         

        Overnight Delivery should be mailed or hand
        delivered to the address located in Block 16
	 	 	 ̈  SERVICE
        DISABLED VETERAN OWNED SMALL BUSINESS 

         ̈  8(A)
	

	11.
    DELIVERY FOR FOB DESTINATION UNLESS BLOCK IS MARKED	12.
    DISCOUNT TERMS	 ̈
    13a. THIS CONTRACT IS A RATED ORDER UNDER 	13b. RATING	 
	 

         ̈ SEE SCHEDULE
	Net
    30 Days	DPAS
    (15 CFR 700)	14. METHOD OF SOLICITATION

         ̈ RFQ    ̈ IFB     x RFP

	15. DELIVER TO

         
	CODE	 	 	16. ADMINISTERED BY

         
	CODE	 
	TO
    BE SHOWN ON EACH ORDER ISSUED UNDER ANY CONTRACT RESULTING FROM THIS SOLICIATION	VA NATIONAL ACQUISITION CENTER

        FEDERAL SUPPLY SCHEDULE SERVICE 001AL-A2-2

        1ST AVENUE, 1 BLOCK NORTH OF 22ND
        STREET

        BLDG 37

        HINES, IL 60141

	17a. CONTRACTOR/

    OFFEROR   CODE	SZ569 	FACILITY
    CODE	 	18a.
    PAYMENT WILL BE MADE BY	CODE	 
	 

        Itamar Medical, Inc.

        842 Upper Union Street, Suite 2

        Franklin, MA 02038

         

        DUNS 61-985-1327

        TELEPHONE NO. 888-748-2627

         
	 	 

        SEE BLOCK 15

         
	 	 
	 	 	 	 	 	 

	 ̈
    17b. CHECK IF REMITTANCE IS DIFFERENT AND PUT SUCH ADDRESS IN OFFER	18b.
    SUBMIT INVOICES TO ADDRESS SHOWN IN BLOCK 18a UNLESS BLOCK BELOW IS CHECKED  ̈
    SEE ADDENDUM

	19. 

        ITEM NO.
	20.
    

    SCHEDULE OF SUPPLIES/SERVICES	21.

        QUANTITY
	22.

        UNIT
	23.

        UNIT PRICE
	24.

        AMOUNT

	FSC CLASS

         6510

        6515

        6530

        6532
	SIN

        A-50H

         

        FSC Group 65, Part II, Section A

         

        Medical Equipment and Supplies

         

        See Continuation of SF-1449 for Schedule of Items

         

        (Attach Reverse and/or Attach Additional
        Sheets as Necessary)
	 	 	 	 

	25. ACCOUNTING AND APPROPRIATION DATA

         

        SEE BLOCK 15 
	26. TOTAL AWARD AMOUNT (For Govt. Use Only)

         

        ESTIMATED VALUE $7,700,000 (10 years)

	 ̈
    27a. SOLICITATION INCORPORATES BY REFERENCE FAR 52.212-1, 52.212-4. FAR 52.212-3 AND
    52.212-5 ARE ATTACHED. ADDENDA	x ARE	 ̈
    ARE NOT ATTACHED.
	 ̈
    27b. CONTRACT/PURCHASE ORDER INCORPORATES BY REFERENCE FAR 52.212-4. FAR 52.212-5 IS
    ATTACHED. ADDENDA	 ̈
    ARE	 ̈
    ARE NOT ATTACHED

 

	x
    28. CONTRACTOR IS REQUIRED TO SIGN THIS DOCUMENT AND RETURN 1  COPIES TO ISSUING
    OFFICE. CONTRACTOR AGREES TO FURNISH AND DELIVER ALL ITEMS SET FORTH OR OTHERWISE IDENTIFIED ABOVE AND ON ANY ADDITIONAL SHEETS
    SUBJECT TO THE TERMS AND CONDITIONS SPECIFIED.	x
    29. AWARD OF CONTRACT: REFERENCE  FPR  OFFER DATED 5/28/2013 YOUR OFFER
    ON SOLICITATION (BLOCK 5), INCLUDING ANY ADDITIONS OR CHANGES WHICH ARE SET FORTH HEREIN, IS ACCEPTED AS TO ITEMS: 

    

    See Summary of Award.

	30a.
    SIGNATURE OF OFFEROR/CONTRACTOR	31a.
    UNITED STATES OF AMERICA (SIGNATURE OF CONTRACTING OFFICER)
	/s/
    Robert D. Grimm	 

	30b. NAME AND TITLE OF SIGNER (TYPE OR PRINT)

         

        Robert D. Grimm, CPCM, Consultant to Itamar 
	30c. DATE SIGNED

        October 12, 2011
	31b. NAME OF CONTRACTING OFFICER (Type or print)

         

        Nancy S. Keating
	31c. DATE SIGNED

 

	AUTHORIZED FOR LOCAL REPRODUCTION

        PREVIOUS EDITION IS NOT
        USABLE
	STANDARD FORM 1449 (REV. 3/2005)

        Prescribed by GSA - FAR (48 CFR) 53.212

 

    	 	 	 

     

    

  

Addenda
to SF-1449

Summary of Award

VA FSS Contract V797D-30190

 

The use of this Government contract
to solicit Government business for non-contract products is fraudulent and subject to prosecution.

 

		 	 

 

    	 	 	 

     

    

 

Contract
Documents

 

Itamar Medical Inc.’s 65IIA
Medical Equipment and Supplies contract under Federal Supply Schedule Solicitation RFP-797-FSS-99-0025-R7, effective June
1, 2013 through, May 31, 2018, consists of the following documents:

 

FAR 52.212-4 Contract Terms and Conditions – Commercial
Items and Addenda

 

FAR 52.212-5 Contract Terms and Conditions Required to Implement
Statutes or Executive Orders – Commercial Items

 

The contractor will participate in Public Law 109-364 Disaster
Recovery Purchasing Program.

 

The contractor will participate in Public Law 111-5 American
Recovery and Reinvestment Act.

 

	Amendment(s)	 	Amendment 0001

        Amendment 0002

        Amendment 0003

        Amendment 0004

	 	 	 
	Proposal	 	Itamar Medical, Inc.offer dated 10/12/2011
	 	 	 
	Revision(s) – revise to be same as cover page section	 	07/10/2012 Clarification letter

        07/12/2012 Amendments and Price Proposal Spreadsheet

        10/30/2012 Commercial Pricelist/Price proposal Excel

        11/26/2012 Price FSS Proposal freight charges, 01/2013,

        02/2013, 03/2013, 04/2013, 05/2013-freight charges
        in price

        proposal, 05/15/2013 Freight 2012 and negotiation,
        5/21/2013

        Kaiser pricing and current Itamar prices, 05/23/2013
        the final

        negotiated prices and there were discrepancies, 05/31/2013
        a

        revised FPR letter.

	 	 	 
	Final Proposal Revision Letter	 	05/21/2013, 05/31/2013

        Brian Sutherland

	 	 	 
	Subcontracting Plan	 	None
	 	 	 
	Commerical Pricelist	 	Itamar's Commercial Pricelist of 10/19/2012
	 	 	 
	Awarded Pricing	 	A copy of the awarded line items with prices (including IFF) is
    attached hereto and made a part hereof.

 

    	 	 	 

     

    

 

	 	a.	Pricing Terms and Conditions
    as agreed to are listed below:

 

	 	Awarded Special Item Number(s) &
    Maximum Order	 	Example: A-10 ($50,000)
    A-50H
	 	Basic Discount	 	0.33%-49.0%
	 	 	 	Net Discounts are reduced by 1% to compensate
    for FOB Destination freight terms.
	 	Quantity Discount (Per SIN)	 	3% additional discount for single orders
    of $25,000 - $100,000
	 	 	 	5% additional discount for single orders
    of $100,001-$200,000
	 	 	 	10% additional discount for single orders
    of $200,001 and over
	 	Payment Terms	 	Net 30 Days
	 	Minimum Order	 	None
	 	Standard Delivery Time	 	21 Days ARO
    (After Receipt of Order)
	 	Expedited Delivery Time	 	1-2 Days up to 7 Days ARO (After
        Receipt of Order)

        The government will pay the difference
        between normal and expedited delivery charges.

	 	FOB Point(s)	 	FOB Destination:
    48 continuous States and to point of exportation to Alaska, Hawaii and Puerto Rico
	 	Warranty Provision	 	See Attachment
    1
	 	Returned Goods Policy	 	See Attachment
    2
	 	Installation	 	None
	 	Training	 	None
	 	Annual Rebate	 	None
	 	Credit Card Acceptance	 	Yes, the offeror accepts credit
    cards up to, equal to and above the micropurchase threshold of $3,000.
	 	Rental/Lease Agreement	 	None
	 	Service Agreement	 	None
	 	Commercial Price List	 	Itamar Medical,
    Inc. Commercial Pricelist of October 19, 2012. This pricelist is verbatim extract of Itamar’s order entry system as
    of October 19,2012
	 	Medical/Surgical Prime Vendor Program Participation	 	Not Participating
	 	Direct-to-Patient Distribution Program	 	Not Participating
	 	Disaster Recovery Act	 	Participating
	 	Public Health Emergencies	 	Participating
	 	No Awards	 	None
	 	Additional Terms Offered/Agreed to but not listed
    above:	 	•      Itamar
        elects not to participate om the prime vendor program, direct ot patient distribution, consignment agreements the ARRA
        of 2009.

        •      Itamar
        will participate in the Public Health Emergency and Disater Recovery Act.

        •      Tracking
        ratios and FSS price before and after IFF are correct as stated in the FPR letter and correspond to the file: EX 5 R8
        Final OfferToGov’t-

        Itamar_w1%FrtDeductFromFSSdiscountToVA.xlsx.

  

    	 	 	 

     

    

 

b.   
Tracking Customer

 

552.238-75 Price Reduction
Clause and 552.243-72 Modifications for the purpose of the Price Reduction provisions and Price Increase provisions of this contract,
the Government and contractor agree that this contract shall be predicated on the following customer(s) or category(ies) of customer(s):
Universities. During the course of this contract, for any sales under the maximum order, the price relationship of 0.75-1.0 shall
be maintained. This is not applicable for deviation sales previously disclosed.

 

If the identified tracking
customer’s contract/agreement has been canceled, terminated, has expired, or the tracking customer has merged with another
group, the assigned contract specialist shall be notified within 10 days after the event occurs, and if possible, before
the event occurs. At such time the Contractor will negotiate in good faith with the Contracting Officer to establish a successor
tracking customer.

 

c.   
Economic Price Adjustment

 

552.216-70 Economic Price Adjustment
Clause – FSS Multiple Award Schedule Contracts (of the solicitation applies to all items awarded under this contract.

 

d.   
Annual Rebate

 

An annual rebate has not
been negotiated and awarded under this contract.

 

e.   
Tax ID Number

 

Your Tax I.D. number may be
included on the published pricelist to facilitate payment by ordering activities.

 

The sole purpose of funds provided by
the accounting data in Block 25 of the SF1449 is to fund the guaranteed minimum of $2,500 as stated in contract clause l-FSS-106;
however, the funds obligated at time of award do not constitute an order for supplies or services under this contract.

 

    	 	 	 

     

    

 

Itamar Medical, Inc.

AWARDED PRICING

 

“A” = Awarded

  

	 	 	 	 	 	 	 	 	 	 	Qty in	 	 	 	 	 	 	 	 	FSS Price	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 	 	 	 	Unit	 	 	 	 	 	Tracking	 	 	w/out	 	 	FSS Price *	 	 	FSS Price	 	 	Tracking	 
	 	 	 	Product /	 	 	 	Unit of	 	 	Of	 	 	Tracking	 	 	Customer	 	 	Freight &	 	 	1.01 for	 	 	FOB Dest	 	 	Customer	 
	SIN	 	 	Item Number	 	Product Description	 	Sale	 	 	Pkg	 	 	Customer	 	 	Price	 	 	IFF	 	 	Freight	 	 	with IFF	 	 	Ratio	 
	 	A-50h	 	 	AC00016XX	 	ED2000 Accessories	 	 	EA	 	 	 	1	 	 	 	Universities	 	 	$	450.00	 	 	$	402.50	 	 	$	406.53	 	 	$	408.57	 	 	 	0.89	 	A
	 	A-50h	 	 	AC05720XX	 	Set of 30 Anchors	 	 	EA	 	 	 	30	 	 	 	Universities	 	 	$	10.00	 	 	$	7.50	 	 	$	7.58	 	 	$	7.61	 	 	 	0.75	 	A
	 	A-50h	 	 	AC16000XX	 	12 Pneumatic Endo probes	 	 	EA	 	 	 	12	 	 	 	Universities	 	 	$	240.00	 	 	$	214.25	 	 	$	216.39	 	 	$	217.48	 	 	 	0.89	 	A
	 	A-50h	 	 	AC20001XX	 	Adhesive Set for Sensor	 	 	EA	 	 	 	12	 	 	 	Universities	 	 	$	32.70	 	 	$	32.70	 	 	$	33.03	 	 	$	33.19	 	 	 	1.00	 	A
	 	A-50h	 	 	AC20002XX	 	Integrated Sensor	 	 	EA	 	 	 	1	 	 	 	Universities	 	 	$	376.50	 	 	$	376.50	 	 	$	380.27	 	 	$	382.18	 	 	 	1.00	 	A
	 	A-50h	 	 	AC20003XX	 	24 Bracelets for Watch PAT	 	 	EA	 	 	 	24	 	 	 	Universities	 	 	$	307.00	 	 	$	307.00	 	 	$	310.07	 	 	$	311.63	 	 	 	1.00	 	A
	 	A-50h	 	 	AC21002XX	 	12 Pneumo-Opt slp Probes	 	 	EA	 	 	 	12	 	 	 	Universities	 	 	$	480.00	 	 	$	472.50	 	 	$	477.23	 	 	$	479.62	 	 	 	0.98	 	A
	 	A-50h	 	 	AC21006XX	 	zzzPAT S/W Kit For WP100/WP200 (US) 4.2	 	 	EA	 	 	 	1	 	 	 	Universities	 	 	$	500.00	 	 	$	475.00	 	 	$	479.75	 	 	$	482.16	 	 	 	0.95	 	A
	 	A-50h	 	 	AC21104XX	 	Watch-PAT200 Kit	 	 	EA	 	 	 	1	 	 	 	Universities	 	 	$	4,700.00	 	 	$	3,900.00	 	 		3900	 	 	$	3,919.60	 	 	 	0.83	 	A
	 	A-50h	 	 	AS0060520	 	Oximeter sensor for WP200	 	 	EA	 	 	 	1	 	 	 	Universities	 	 	$	160.00	 	 	$	142.50	 	 	$	143.93	 	 	$	144.65	 	 	 	0.89	 	A
	 	A-50h	 	 	AS0060590	 	PAT Cable WP200	 	 	EA	 	 	 	1	 	 	 	Universities	 	 	$	60.00	 	 	$	52.50	 	 	$	53.03	 	 	$	53.29	 	 	 	0.88	 	A
	 	A-50h	 	 	AS16400XX	 	Moxa Assy for Endo-PAT	 	 	EA	 	 	 	1	 	 	 	Universities	 	 	$	80.00	 	 	$	70.50	 	 	$	71.21	 	 	$	71.56	 	 	 	0.88	 	A
	 	A-50h	 	 	CP72000XX	 	Oximeter adhesive bands x 25	 	 	EA	 	 	 	25	 	 	 	Universities	 	 	$	15.00	 	 	$	13.80	 	 	$	13.94	 	 	$	14.01	 	 	 	0.92	 	A
	 	A-50h	 	 	CS1000101	 	1 Year Warranty Watch-PAT	 	 	EA	 	 	 	1	 	 	 	Universities	 	 	$	425.00	 	 	$	403.75	 	 	$	403.75	 	 	$	405.78	 	 	 	0.95	 	A
	 	A-50h	 	 	CS1000102	 	2 Year Warranty Watch-PAT	 	 	EA	 	 	 	1	 	 	 	Universities	 	 	$	800.00	 	 	$	760.00	 	 	$	760.00	 	 	$	763.82	 	 	 	0.95	 	A
	 	A-50h	 	 	CS10025XX	 	Minor Repair and Inspection WatchPAT	 	 	EA	 	 	 	1	 	 	 	Universities	 	 	$	180.00	 	 	$	171.00	 	 	$	171.00	 	 	$	171.86	 	 	 	0.95	 	A
	 	A-50h	 	 	CS2000101	 	1 Year Warranty Endo-PAT	 	 	EA	 	 	 	1	 	 	 	Universities	 	 	$	1,400.00	 	 	$	1,330.00	 	 	$	1,330.00	 	 	$	1,336.68	 	 	 	0.95	 	A
	 	A-50h	 	 	CS2000102	 	2 Year Warranty Endo-PAT	 	 	EA	 	 	 	1	 	 	 	Universities	 	 	$	2,500.00	 	 	$	2,375.00	 	 	$	2,375.00	 	 	$	2,386.93	 	 	 	0.95	 	A
	 	A-50h	 	 	CS2000105	 	5 Year Warranty Endo-PAT	 	 	EA	 	 	 	1	 	 	 	Universities	 	 	$	4,000.00	 	 	$	3,800.00	 	 	$	3,800.00	 	 	$	3,819.10	 	 	 	0.95	 	A
	 	A-50h	 	 	FG16000XX	 	Endo-PAT2000 KitTypel6	 	 	EA	 	 	 	1	 	 	 	Universities	 	 	$	24,687.50	 	 	$	24,743.75	 	 	$	24,991.19	 	 	$	25,116.77	 	 	 	1.00	 	A
	 	A-50h	 	 	FG21610XX	 	Oximeter sensor for WP100	 	 	EA	 	 	 	1	 	 	 	Universities	 	 	$	140.00	 	 	$	140.00	 	 	$	141.40	 	 	$	142.11	 	 	 	1.00	 	A
	 	A-50h	 	 	FG21620XX	 	Cable conn Probe - WP100	 	 	EA	 	 	 	1	 	 	 	Universities	 	 	$	60.00	 	 	$	52.50	 	 	$	53.03	 	 	$	53.29	 	 	 	0.88	 	A
	 	A-50h	 	 	FG21701XX	 	Sleeve Disposable x25	 	 	EA	 	 	 	25	 	 	 	Universities	 	 	$	15.00	 	 	$	13.70	 	 	$	13.84	 	 	$	13.91	 	 	 	0.91	 	A
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Min	 	 	 	0.75	 	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Max	 	 	 	1.00	 	 

 

Note: there are 23 PNs being offered to the Gov’t.

 

    	 	 	 

     

    

 

Itamar Medical,
Inc.

Commercial Price List as of October 19, 2012

 

	Product 

    Code	 	SIN	 	 	VA Product
 Code	 	Product Name	 	List Price as of

    Oct. 19, 2012	 
	AC0001600	 	 	A-94	 	 	AC00016XX	 	ED2000 Accessories	 	$	450.00	 
	AC0572070	 	 	A-94	 	 	AC05720XX	 	Set of 30 Anchors	 	$	10.00	 
	AC1600004	 	 	A-94	 	 	AC16000XX	 	12 Pneumatic Endo probes	 	$	240.00	 
	AC2000100	 	 	A-50h	 	 	AC20001XX	 	Adhesive Set for Sensor	 	$	38.00	 
	AC2000201	 	 	A-50h	 	 	AC20002XX	 	Integrated Sensor	 	$	420.00	 
	AC2000300	 	 	A-50h	 	 	AC20003XX	 	24 Bracelets for WatchPAT	 	$	384.00	 
	AC2100210	 	 	A-50h	 	 	AC21002XX	 	12 Pneumo-Opt sip Probes	 	$	600.00	 
	AC2100617	 	 	A-50h	 	 	AC21006XX	 	zzzPAT S/W Kit For WP100/WP200 (US)	 	$	950.00	 
	AC2110307	 	 	A-50h	 	 	AC21104XX	 	Watch-PAT200 Kit	 	$	4,950.00	 
	AS0060520	 	 	A-50h	 	 	AS0060520	 	Oximeter sensor for WP200	 	$	160.00	 
	AS0060590	 	 	A-50h	 	 	AS0060590	 	PAT Cable WP200	 	$	60.00	 
	AS1640002	 	 	A-94	 	 	AS16400XX	 	Moxa Assy for Endo-PAT	 	$	80.00	 
	CP7200010	 	 	A-50h	 	 	CP72000XX	 	Oximeter adhesive bands x 25	 	$	17.00	 
	CS1000101	 	 	A-50h	 	 	CS1000101	 	1 Year Warranty Watch-PAT	 	$	425.00	 
	CS1000102	 	 	A-50h	 	 	CS1000102	 	2 Year Warranty Watch-PAT	 	$	800.00	 
	CS1002501	 	 	A-50h	 	 	CS10025XX	 	Minor Repair and Inspection WatchPAT	 	$	180.00	 
	CS2000101	 	 	A-94	 	 	CS2000101	 	1 Year Warranty Endo-PAT	 	$	1,400.00	 
	CS2000102	 	 	A-94	 	 	CS2000102	 	2 Year Warranty Endo-PAT	 	$	2,500.00	 
	CS2000105	 	 	A-94	 	 	CS2000105	 	5 Year Warranty Endo-PAT	 	$	4,000.00	 
	FG1600016	 	 	A-94	 	 	FG16000XX	 	Endo-PAT2000 Kit Type l6	 	$	27,500.00	 
	FG2161001	 	 	A-50h	 	 	FG21610XX	 	Oximeter sensor for WP100	 	$	160.00	 
	FG2162002	 	 	A-50h	 	 	FG21620XX	 	Cable conn Probe - WP100	 	$	60.00	 
	FG2170102	 	 	A-50h	 	 	FG21701XX	 	Sleeve Disposable x25	 	$	15.00	 

 

This pricelist is a verbatim extract
of Itamar’s order entry system as of October 19,

 

    	 	 	 

     

    

 

Itamar Medical,
Inc.

 

Attachment 1

 

Warranty: The Contractor
guarantees the product furnished will be free from defects in material and workmanship for a period of one (1) year from date
of delivery. The Contractor will replace, at its option, all parts found defective within the period with cost of replacement,
including shipping charge, to be borne by the Contractor. Under no circumstances will any equipment covered by this guarantee
be returned without (a) advance notice to the Contractor, or (b) obtaining shipping instructions from the Contractor.

 

    	 	 	 

     

    

 

Itamar Medical,
Inc.

 

Attachment 2

 

Return Policy: All
items must be returned in their original package within 30 days from date of delivery. In the event that a shipping error occurs
due to contractor’s error, contractor will pay freight both ways for return/exchange of products. If an ordering facility
error occurs, the ordering facility will pay return freight. No restocking fee will apply either way. Please call 1-888-748-2627
for a return authorization number (RA#).

 

    	 	 

     

    

 

 

	SOLICITATION/CONTRACT/ORDER FOR
        COMMERCIAL ITEMS

        OFFEROR TO COMPLETE BLOCKS 12, 17,
        23, 24, & 30
	1.
    REQUISITION NO.	PAGE
    1 OF 18
	2. CONTRACT NO.

         

            V797D-30190
	3. AWARD/EFFECTIVE DATE

         

            See Block 31
	4. ORDER NO.

         

            VA260-12-A-0023A
	5. SOLICITATION NUMBER

         

        VA260-12-Q-0065
	6.
    SOLICITATION ISSUE DATE
	7. FOR SOLICITATION

          INFORMATION CALL:
	a. NAME

        Chris Towery
	 	b.
    TELEPHONE NO. (No Collect Calls) 509-321-1911	8.
    OFFER DUE DATE/LOCAL TIME

	9. ISSUED BY 	CODE	 	260	10. THIS ACQUISITION IS	x  UNRESTRICTED OR	 ̈ SET ASIDE: ___%
    FOR:
	 

        Department of Veterans Affairs

        Network Contracting Office 20

        8524 N. wall St

         

        Spokane WA 99208
	 	 ̈ SMALL
        BUSINESS

         

         ̈ HUBZONE
        SMALL  

         BUSINESS

         

         ̈ SERVICE-DISABLED
         

         VETERAN-OWNED  

         SMALL BUSINESS

         
	 ̈  WOMEN-OWNED
        SMALL BUSINESS

        (WOSB) ELIGIBLE UNDERE THE WOMEN-OWNED

        SMALL BUSINESS PROGRAM

         

         ̈  EDWOSB

         

         ̈  8(A)
	 

         

         

         

         

         

         

         

         NAICS:   423450

         

        SIZE STANDARD:

        100 Employees

	11.
    DELIVERY FOR FOB DESTINATION UNLESS BLOCK IS MARKED	12.
    DISCOUNT TERMS	 ̈
    13a. THIS CONTRACT IS A RATED ORDER UNDER 	13b. RATING

        N/A
	 
	 ̈
    SEE SCHEDULE	 	DPAS
    (15CFR 700)	14. METHOD OF SOLICITATION

        x RFQ    ̈
        IFB      ̈ RFP

	15. DELIVER TO

         
	CODE	 	260	16. ADMINISTERED BY

         
	CODE	 
	See
    Delivery Orders	 	 	 

        Department of Veterans Affairs

        Network Contracting Office 20

        8524 N. wall St

         

        Spokane WA 99208

	17a. CONTRACTOR/

    OFFICEROR    CODE	 	FACILITY
    CODE	 	18a. PAYMENT WILL
    BE MADE BY	CODE	 
	 

        ITAMAR MEDICAL, INC

         

        842 Upper Union St Ste 2

         

        Franklin, MA 02038

         

        TELEPHONE NO.

         
	 	DUNS:
    619851327 DUNS+4:	 

        Department of Veterans Affairs

        FMS-VA-2 (101)

        Financial Service Center

        PO Box 149971

        Austin TX 78714-9971

         

        PHONE:
	FAX:	 
	 	 	 	 	 	 

	 ̈
    17b. CHECK IF REMITTANCE IS DIFFERENT AND PUT SUCH ADDRESS IN OFFER	18b. SUBMIT INVOICES TO ADDRESS SHOWN
        IN BLOCK 18a UNLESS BLOCK BELOW IS CHECKED

        x
        SEE ADDENDUM

	19. 

        ITEM NO.
	20.
    

    SCHEDULE OF SUPPLIES/SERVICES	21.

        QUANTITY
	22.

        UNIT
	23.

        UNIT PRICE
	24.

        AMOUNT

	 	Federal Supply Schedule Blanket Purchase Agreement to provide
        portable sleep monitoring devices and associated consumables for such devices throughout VISN 20.

         

        The original BPA# VA26Q-12-A-0Q23 referenced the vendor’s
        previous NAC contract number. This document provides the means to reference the vendor's new NAC FSS Contract Number V797D-30190
        and establishes a new BPA# VA260-12-A-Q023A All terms and conditions, period of performances remain the same from the
        original BPA. Merely an administrative action to ensure all orders placed against the BPA reference the vendors valid
        NAC FSS Contract Number.

         

        VA POC: Chris Towery

        e-mail: christopher.towery@va.gov

        509-321-1911

         

        (Use Reverse and/or Attach Additional
        Sheets as Necessary)
	 	 	 	 

	25.
    ACCOUNTING AND APPROPRIATION DATA	26. TOTAL AWARD AMOUNT (For Govt. Use Only)

         

        $0.00

 

	 ̈
    27a. SOLICITATION INCORPORATES BY REFERENCE FAR 52.212-1,52.212-4. FAR 52.212-3 AND 62.212-5
    ARE ATTACHED. ADDENDA	 ̈ ARE	 ̈ ARE
    NOT ATTACHED.
	 ̈
    27b. CONTRACT/PURCHASE ORDER INCORPORATES BY REFERENCE FAR 52.212-1. FAR 52.212-6 IS
    ATTACHED. ADDENDA	 ̈
    ARE	 ̈
    ARE NOT ATTACHED

	 ̈
    28. CONTRACTOR IS REQUIRED TO SIGN THIS DOCUMENT AND RETURN COPIES TO ISSUING OFFICE.
    CONTRACTOR AGREES TO FURNISH AND DELIVER ALL ITEMS SET FORTH OR OTHERWISE IDENTIFIED ABOVE AND ON ANY ADDITIONAL SHEETS SUBJECT
    TO THE TERMS AND CONDITIONS SPECIFIED	 ̈
    29. AWARD OF CONTRACT: REF. _______________OFFER DATED________________________. YOUR
    OFFER ON SOLICITATION (BLOCK 5), INCLUDING ANY ADDITIONS OR CHANGES WHICH ARE SET FORTH HEREIN IS ACCEPTED AS TO ITEMS:
	30a.
    SIGNATURE OF OFFEROR/CONTRACTOR	31a.
    UNITED STATES OF AMERICA (SIGNATURE OF CONTRACTING OFFICER)
	/s/
    Arnon Tuval	/s/
    Brian Thomas

	30b. NAME AND TITLE OF SIGNER (TYPE OR PRINT)

        

        Arnon Tuval

        VP Operations

         
	30c. DATE SIGNED

        3/12/14
	31b. NAME OF CONTRACTING OFFICER (TYPE OR PRINT)

         

        Brian Thomas

        V2012L3-0563
	31c. DATE SIGNED

        3/12/2014

 

	AUTHORIZED FOR LOCAL REPRODUCTION

        PREVIOUS EDITION IS NOT
        USABLE
	STANDARD FORM 1449 (REV. 2/2012)

        Prescribed by GSA - FAR (46 CFR) 53.212

 

    	 	 	 

     

    

 

Table of Contents

 

	SECTION A	1
	 	 
	A.1 SF 1449 SOLICITATION/CONTRACT/ORDER FOR COMMERCIAL ITEMS	1
	 	 
	SECTION B - CONTINUATION OF SF 1449 BLOCKS	3
	 	 
	B.l PRICE/COST SCHEDULE	3
	B.2 ADMINISTRATIVE DATA	4
	B.3 CONTRACT ADMINISTRATION DATA	5
	B.4 AUTHORITY	6
	B.5 DESCRIPTION OF AGREEMENT	6
	B.6 PRICING	6
	B.7 PREVAILING TERMS AND CONDITIONS	7
	B.8 TERM OF BPA	7
	B.9 EXTENT OF OBLIGATIONS	7
	B.10 PURCHASE LIMITATION	7
	B.11 INDIVIDUALS AUTHORIZED TO PURCHASE UNDER BPA	7
	B.12 BILLING AND INVOICES	7
	B.13 VA POC RESPONSIBILITIES	8
	B. l4 CONTRACTOR RESPONSIBILITIES	9
	B. l5 SECURITY REQUIREMENTS	9
	B. l6 TECHNICAL QUALIFICATIONS AND REQUIREMENTS	9
	B. l7 PROHIBITION OF ADVERTISING OF AWARD	10
	B. l8 TAX EXEMPT	11
	 	 
	SECTION C - CONTRACT CLAUSES	12
	 	 
	C.l 52.246-17 WARRANTY OF SUPPLIES OF A NONCOMPLEX NATURE (JUNE
    2003)	12
	C.2 52.217-8 OPTION TO EXTEND SERVICES (NOV 1999)	14
	C.3 52.217-9 OPTION TO EXTEND THE TERM OF THE CONTRACT (MAR
    2000)	14
	C.4 52.237-3 CONTINUITY OF SERVICES (JAN 1991)	14
	C.5 VAAR 852.203-70 COMMERCIAL ADVERTISING (JAN 2008)	15
	C.6 VAAR 852.211-70 SERVICE DATA MANUALS (NOV 1984)	15
	C.7 VAAR 852.211-73 BRAND NAME OR EQUAL (JAN 2008)	16
	C.8 VAAR 852.237-70 CONTRACTOR RESPONSIBILITIES (APR 1984)	17
	C.9 VAAR 852.246-70 GUARANTEE (JAN 2008)	17
	C.10 VAAR 852.246-71 INSPECTION (JAN 2008)	17
	C.11 Notice: Mandatory Electronic Invoicing	18

 

    	 	 	 

     

    

 

SECTION B - CONTINUATION OF SF 1449 BLOCKS

 

B. I price/cost
SCHEDULE

 

BASE YEAR: 4/1/2012 - 3/31/2013

 

	Item Number 0001	 	 	1
                                         JB	 	 	 	8	%

 

Percentage discount rate off the Vendor’s complete federal
supply schedule catalog.

 

OPTION YEAR 1: 4/1/2013 - 3/31/2014

 

	Item Number 0001	 	 	1
                                         JB	 	 	 	8	%

 

Percentage discount rate off the Vendor’s complete federal
supply schedule catalog.

 

OPTION YEAR 2: 4/1/2014 - 3/31/2015

 

	Item Number 0001	 	 	1
                                         JB	 	 	 	8	%

 

Percentage discount rate off the Vendor’s complete federal
supply schedule catalog.

 

OPTION YEAR 3: 4/1/2015 - 3/31/2016

 

	Item Number 0001	 	 	1
                                         JB	 	 	 	8	%

 

Percentage discount rate off the Vendor’s complete federal
supply schedule catalog.

 

OPTION YEAR 4: 4/1/2016 - 3/31/2017

 

	Item Number 0001	 	 	1
                                         JB	 	 	 	8	%

 

Percentage discount rate off the Vendor’s complete federal
supply schedule catalog.

 

	GRAND TOTAL	8	%	Mean Discount Rate for Base + 4 Option Years

 

    	 	3	 

     

    

 

Pursuant to General Services Administration (GSA) Federal Supply
Schedule (FSS) contract number(s) V797D-30190 (“Contract(s)”), a Blanket Purchase Agreement (BPA) is hereby
established between Itamar-Medical Inc. and the Network Contracting Office(NCO) 20 VA Healthcare Network under the terms
and conditions of the above stated contract(s) and the following terms and conditions incorporated in this BPA:

 

	B.2 ADMINISTRATIVE DATA	 
	 	 
	1. Primary Point of Contact:	Arnon Tuval
	 	 
	 	VP of Operations, HR, & Contract Compliance
	 	 
	 	Itamar Medical Inc.
	 	 
	 	842 Upper Union Street, #2
	 	 
	 	Franklin, MA 02038
	 	 
	 	tarnon@itamar-medical.com
	 	 
	 	Ph# 508-808-0597
	 	 
	2. Alternate Point of Contact:	 
	 	 
	 	Christopher Hallett
	 	 
	 	VP of Sales
	 	 
	 	Itamar Medical Inc.
	 	 
	 	842 Upper Union Street, #2
	 	 
	 	Franklin, MA 02038
	 	 
	 	hchris@itamar-medical.com
	 	 
	DUNS Number: 531857076	 
	 	 
	TIN: 51-04060927	 

 

    	 	4	 

     

    

 

B.3 CONTRACT ADMINISTRATION DATA

 

1. Contract Administration: All contract
administration matters shall be handled by the following individuals:

 

a. CONTRACTOR: Itamar Medical Inc.

 

b. GOVERNMENT: Contracting Officer 00260

 

Department of Veterans Affairs

 

Contracting & Purchasing (90C)

 

8524 N. Wall St

 

Spokane WA 99208

 

2. CONTRACTOR REMITTANCE ADDRESS: All
payments by the Government to the contractor shall be made in accordance with:

 

x
52.232-34, Payment by Electronic Funds Transfer -Other than Central Contractor Registration, or

 

 ̈
52.232-36, Payment by Third Party

 

3. INVOICES: Invoices shall be submitted
in arrears:

 

	a. Quarterly	 ̈
	 	 
	b. Semi-Annually	 ̈
	 	 
	c. Other	[Upon Receipt and Acceptance]

 

    	 	5	 

     

    

 

B.4 AUTHORITY

 

		1.	This
                                         BPA is entered into pursuant to the terms of the BPA holder’s FSS contract, FAR
                                         13.303 and FAR 8.404.

 

B.5 DESCRIPTION OF AGREEMENT

 

		1.	The
                                         contractor agrees to the following terms of a blanket purchase agreement (BPA) exclusively
                                         with the Department of Veterans Affairs, VA NW Health Network (NCO20).

 

		2.	Under
                                         this agreement, the BPA holder shall provide Portable Sleep Monitoring Devices worn on
                                         the wrist and finger probe consumables associated with such devices to include service
                                         and maintenance.

 

		3.	The
                                         BPA will provide a single Item Number for a percentage discount rate off the Vendor’s
                                         complete Federal Supply Schedule (FSS) catalog. Any items associated with the sleep study
                                         devices to include consumables and maintenance of said items shall be available on schedule
                                         throughout the life of the BPA. The complete current FSS schedule catalog shall be provided
                                         to the Contracting Officer (CO) and attached to the executed BPA. As new items are added
                                         or deleted from the FSS contract the contractor shall provide an updated pricing list
                                         to the Contracting Officer within 14 days of any modifications.

 

		4.	The
                                         supplies and/or services shall be ordered by an authorized Contracting Officer during
                                         the specified period stated in the paragraph titled “Term of BPA”. This BPA
                                         is for support to NCO20 VA Healthcare Network (including geographically separated units
                                         and operating locations) only.

 

B.6 PRICING

 

		1.	The
                                         GSA Schedule pricing has been determined fair and reasonable by the GSA according to
                                         FAR 8.404(d). The prices (loaded labor rates) included on the BPA list (or applicable
                                         “discounted” rates submitted in a proposal response to an RFQ resulting in
                                         award) that are in effect on the effective date of an order shall govern that order’s
                                         basic performance period. The BPA holder shall update the BPA price list within 24 hours
                                         of a change in their Schedule prices to insure that the BPA pricing remains current.

 

		2.	The
                                         BPA holder can voluntarily reduce offered prices or increase the discount rate at any
                                         time by giving 24-hour advance notice (by facsimile or electronic-mail) to the NCO20
                                         VA Healthcare Network/Contracting Officer. When in effect, the new price list will be
                                         posted on the BPA holder’s Internet site and made immediately available to all
                                         authorized potential BPA users.

 

		3.	In
                                         no event will the prices under this BPA exceed those on the applicable GSA schedule.
                                         Any order already issued shall not be affected by any change to FSS pricing. The prices
                                         offered under this BPA will undergo annual review by the NCO20 Contracting Officer.

 

    	 	6	 

     

    

 

B.7 PREVAILING TERMS
AND CONDITIONS

 

		1.	All
                                         orders placed against this BPA are subject to the terms and conditions of the GSA FSS
                                         Contract and all clauses and provisions in full text or incorporated by reference herein:

 

B.8 TERM OF BPA

 

		1.	This
                                         BPA consists of a Base Year and Four(4) Option years for a total of 5 years from date
                                         of award. The BPA holder is required to immediately notify, in writing, the NCO20 VA
                                         Healthcare Network Contracting Activity/Contracting Officer if at any time prior to expiration
                                         date, the GSA FSS Contract, upon which this BPA is based, is no longer in force. This
                                         BPA is not a contract. If the BPA holder fails to perform in a manner satisfactory to
                                         the NCO20 VA Healthcare Network Contracting Activity Contracting Officer, this BPA may
                                         be canceled with 30 days written notice to the BPA holder by the NCO20 VA Healthcare
                                         Network Contracting Activity Contracting Officer.

 

B.9 EXTENT OF OBLIGATIONS

 

		1.	This
                                         BPA does not obligate any funds. Funds will be obligated as individual orders are requested.

 

		2.	The
                                         Government is obligated only to the extent of authorized orders actually issued under
                                         the BPA by the Contracting Officer.

 

		3.	Supply
                                         orders issued under this agreement shall be Firm Fixed Price. Service orders issued under
                                         this agreement shall be priced either at hourly rates, or at a fixed price for performance
                                         of a specific task.

 

B.10 PURCHASE LIMITATION

 

		1.	Purchase
                                         Limitations for each individual obligation number shall not exceed $150,000.00.

 

B.11 INDIVIDUALS
AUTHORIZED TO PURCHASE UNDER BPA

 

		1.	Government
                                         Contracting Officers representing NETWORK CONTRACTING OFFICE (NCO) 20 VA Healthcare Network
                                         are the only users authorized to place orders under this BPA. Any authorized user shall
                                         only be allowed to issue an order under this BPA if funds are certified and the BPA awarding
                                         office’s Deliver Order or Task Order number is assigned. BPA holders shall not
                                         accept or perform any purported order that does not contain a Delivery Order or Task
                                         Order number.

 

B.12 BILLING AND INVOICES

 

		1.	Orders
                                         will be placed against this BPA via SF 1449’s sent by e-mail to vendor.

 

    	 	7	 

     

    

 

		2.	Unless
                                         otherwise agreed to, all call orders under this BPA must include, at a minimum, the following
                                         information:

 

	 	(a)	Name of Contractor;

 

	 	(b)	BPA Number;

 

	 	(c)	Task Order/Delivery Order Number;

 

	 	(d)	Obligation Number;

 

	 	(e)	Date of Purchase;

 

	 	(f)	Quantity, Unit Price, and Extension of Each Item;

 

	 	(g)	Description of Services (tasks and deliverables if applicable); and

 

	 	(h)	Period of Performance (if applicable)

 

	 	(i)	Date of Delivery (if applicable)

 

		3.	The
                                         requirements of a proper invoice will be specified in the 1449 of each order. Invoices
                                         will be submitted to the address specified within the task order/delivery order issued
                                         against this BPA on the SF1449. In the event of an inconsistency between the provisions
                                         of this BPA and the contractor’s invoice, the provisions of this BPA will take
                                         precedence.

 

		4.	Inspection
                                         and acceptance shall be accomplished as follows for all supplies and services furnished
                                         under any resulting order hereby designate a Point of Contact (POC) in the program office
                                         as the point of final inspection and acceptance. The BPA holder will submit each invoice
                                         to the address in block 18a on page 1, of the SF1449. If the invoice is incomplete or
                                         inaccurate, the invoice will not be processed.

 

		5.	An
                                         itemized invoice shall be submitted to the CO at least monthly or upon expiration of
                                         this BPA, whichever occurs first, for all deliveries made during a billing period and
                                         for which payment has not been received. Copies of delivery tickets shall support these
                                         invoices. “Approved-for-payment” invoices will be submitted to the payment
                                         address specified on each individual order issued under this BPA.

 

		6.	Ensure
                                         each invoice contains the obligation number associated with each order. The obligation
                                         number is different than the order number.

 

		7.	Each
                                         invoice shall list FSS price and discount price for each line item on call order.

 

B.13 VA POC RESPONSIBILITIES

 

		1.	The
                                         CO may designate a Point of Contact (POC) for each delivery order to act as the Project
                                         Manager (PM).

 

	 	a.	Providing the Vendor with an identifiable need and requesting the Vendor
    produce a detailed quote for supplies and/or services.

	 	b.	Coordination with facility departments.

 

    	 	8	 

     

    

 

	 	c.	Ensuring a purchase request is sent to contracting

	 	d.	Ensuring the quote and all pertinent documentation are provided to the
    CO.

	 	e.	Delivery, Inspection and Acceptance.

	 	f.	Ensuring any invoices that require certification are processed, approved
    and certified for payment.

 

B.14 CONTRACTOR RESPONSIBILITIES

 

		1.	The
                                         contractor shall perform when requested by the POC, to establish detailed quotes for
                                         specified requirements that fit within this BPA of supplies and services to be placed
                                         against the BPA.

 

	 	a.	Contractor shall provide detailed quotes to the POC itemizing all services
    and supplies being requested for specified dates.

 

	 	b.	All costs shall be annotated on the quote. Once the order is processed
    by the Contracting Officer, no additional costs may be added for said services and supplies without Contracting Officer approval.

 

	 	c.	Contractor shall deliver services and supplies as specified in the Contracting
    Officer signed order.

 

B.15 SECURITY REQUIREMENTS

 

		1.	The
                                         preliminary and final deliverables, and all associated working papers, application source
                                         code, and other material deemed relevant by VA which have been generated by the contractor
                                         in the performance of this award and any subsequent orders, are the exclusive property
                                         of the U.S. Government and shall be submitted to the CO at the conclusion of the task
                                         order.

 

		2.	The
                                         CO shall be the sole authorized official to release, verbally or in writing, any data,
                                         draft deliverables, final deliverables, or any other written or printed materials pertaining
                                         to this award and any subsequent orders. No information shall be released by the contractor.
                                         Any request for information relating to this task order, presented to the contractor,
                                         shall be submitted to the CO for response.

 

		3.	Press
                                         releases, marketing material, or any other printed or electronic documentation related
                                         to this project, shall not be publicized without the written approval of the CO.

 

B.16 TECHNICAL QUALIFICATIONS AND REQUIREMENTS

 

		1.	Vendors
                                         FSS contract shall contain items that meet the following characteristics to qualify for
                                         BPA.

 

	 	A)	Portable (wrist-watch) sleep diagnostic device.

 

Model: WatchPAT200.

MFR: Itamar

 

Product Number: AC2110307

 

	 	i.	The Sleep Study Devices shall provide the following information:

 

RDI and AHI

 

    	 	9	 

     

    

 

-ODI (Oxygen level)

 

-Heart Rate

 

-Body Position

 

-Snoring Intensity (dB)

 

-Real Sleep Time

 

-Sleep Stages and Architecture (wake/light/deep)

 

-REM/nonREM Sleep

 

-Sleep Fragmentation

 

	 	ii.	The sleep device shall also measure 6 channels:

 

-PAT (Peripheral Arterial Tone)

 

-Oximetry

 

-Actigraphy

 

-Heart Rate

 

-Body Position

 

-Snoring

 

	 	iii.	The sleep monitoring device must be able to
    be worn around wrist and be compatible with finger probes.

 

	 	iv.	Device shall meet AASM standard.

 

B.17 PROHIBITION
OF ADVERTISING OF AWARD 

 

		1.	The
                                         contractor shall not refer to this award in commercial advertising, or similar promotions
                                         in such a manner as to state or to imply that the product or services provided is endorsed,
                                         preferred, or is considered superior to other products or services by the Department
                                         of Veterans Affairs. This includes advertising, or similar promotions, in all forms or
                                         electronic, broadcast, and print media.

 

		2.	In
                                         addition, the contractor is restricted from reproducing the image(s) of the VA in any
                                         form of commercial advertising, or similar promotion. This includes images of official
                                         seals and buildings. Any proposed usage of such symbols must be brought to the attention
                                         of the Contracting Officer (CO).

 

    	 	10	 

     

    

 

B.18 TAX EXEMPT

 

		1.	The
                                         Department of Veterans Affairs, as a Federal Government Agency, is tax exempt in accordance
                                         with the following tax-exempt clauses:

 

52.228-1       State and Local
Taxes (Apr 1994)

 

52.229-4       Federal, State
& Local Taxes (Jan 1991)

 

    	 	11	 

     

    

 

SECTION C - CONTRACT CLAUSES

 

C.1 52.246-17 WARRANTY OF SUPPLIES OF A NONCOMPLEX NATURE
(JUNE 2003)

 

	 	(a)	Definitions. As used in
    this clause—

 

“Acceptance” means the act
of an authorized representative of the Government by which the Government assumes for itself, or as an agent of another, ownership
of existing supplies, or approves specific services as partial or complete performance of the contract.

 

“Supplies” means the end items
furnished by the Contractor and related services required under this contract. The word does not include “data.”

 

	 	(b)	Contractor’s obligations.

 

(1)       Notwithstanding
inspection and acceptance by the Government of supplies furnished under this contract, or any condition of this contract concerning
the conclusiveness thereof, the Contractor warrants that for —

 

(i)       All
supplies furnished under this contract will be free from defects in material or workmanship and will conform with all requirements
of this contract; and

 

(ii)       The
preservation, packaging, packing, and marking, and the preparation for, and method of, shipment of such supplies will conform
with the requirements of this contract.

 

(2)       When
return, correction, or replacement is required, transportation charges and responsibility for the supplies while in transit shall
be borne by the Contractor. However, the Contractor’s liability for the transportation charges shall not exceed an amount
equal to the cost of transportation by the usual commercial method of shipment between the place of delivery specified in this
contract and the Contractor’s plant, and return.

 

(3)       Any
supplies or parts thereof, corrected or furnished in replacement under this clause, shall also be subject to the terms of this
clause to the same extent as supplies initially delivered. The warranty, with respect to supplies or parts thereof, shall be equal
in duration to that in paragraph (b)(1) of this clause and shall run from the date of delivery of the corrected or replaced supplies.

 

(4)       All
implied warranties of merchantability and “fitness for a particular purpose” are excluded from any obligation contained
in this contract.

 

(c)       Remedies
available to the Government.

 

(1)       The
Contracting Officer shall give written notice to the Contractor of any breach of warranties in paragraph (b)(1) of this clause
within.

 

(2)       Within
a reasonable time after the notice, the Contracting Officer may either—

 

(i)       Require,
by written notice, the prompt correction or replacement of any supplies or parts thereof (including preservation, packaging, packing,
and marking) that do not conform with the requirements of this contract within the meaning of paragraph (b)(1) of this clause;
or

 

(ii)       Retain
such supplies and reduce the contract price by an amount equitable under the circumstances.

 

    	 	12	 

     

    

 

(3)(i) If the contract provides for inspection
of supplies by sampling procedures, conformance of supplies or components subject to warranty action shall be determined by the
applicable sampling procedures in the contract. The Contracting Officer—

 

(A) May, for sampling purposes, group
any supplies delivered under this contract;

 

(B) Shall require the size of the sample
to be that required by sampling procedures specified in the contract for the quantity of supplies on which warranty action is
proposed;

 

(C) May project warranty sampling results
over supplies in the same shipment or other supplies contained in other shipments even though all of such supplies are not present
at the point of reinspection; provided, that the supplies remaining are reasonably representative of the quantity on which warranty
action is proposed; and

 

(D) Need not use the same lot size as
on original inspection or reconstitute the original inspection lots.

 

(ii) Within a reasonable time after notice
of any breach of the warranties specified in paragraph (b)(1) of this clause, the Contracting Officer may exercise one or more
of the following options:

 

(A) Require an equitable adjustment in
the contract price for any group of supplies.

 

(B) Screen the supplies grouped for warranty
action under this clause at the Contractor’s expense and return all nonconforming supplies to the Contractor for correction
or replacement.

 

(C) Require the Contractor to screen the
supplies at locations designated by the Government within the contiguous United States and to correct or replace all nonconforming
supplies.

 

(D) Return the supplies grouped for warranty
action under this clause to the Contractor (irrespective of the f.o.b. point or the point of acceptance) for screening and correction
or replacement.

 

(4)(i) The Contracting Officer may, by
contract or otherwise, correct or replace the nonconforming supplies with similar supplies from another source and charge to the
Contractor the cost occasioned to the Government thereby if the Contractor—

 

(A) Fails to make redelivery of the corrected
or replaced supplies within the time established for their return; or

 

(B) Fails either to accept return of the
nonconforming supplies or fails to make progress after their return to correct or replace them so as to endanger performance of
the delivery schedule, and in either of these circumstances does not cure such failure within a period of 10 days (or such longer
period as the Contracting Officer may authorize in writing) after receipt of notice from the Contracting Officer specifying such
failure.

 

(ii) Instead of correction or replacement
by the Government, the Contracting Officer may require an equitable adjustment of the contract price. In addition, if the Contractor
fails to furnish timely disposition instructions, the Contracting Officer may dispose of the nonconforming supplies for the Contractor’s
account in a reasonable manner. The Government is entitled to reimbursement from the Contractor, or from the proceeds of such
disposal, for the reasonable expenses of the care and disposition of the nonconforming supplies, as well as for excess costs incurred
or to be incurred.

 

(5) The rights and remedies of the Government
provided in this clause are in addition to and do not limit any rights afforded to the Government by any other clause of this
contract.

 

(End of Clause)

 

    	 	13	 

     

    

 

C.2 52.2l7-8 OPTION TO EXTEND SERVICES (NOV 1999)

 

The Government may require continued performance
of any services within the limits and at the rates specified in the contract. These rates may be adjusted only as a result of
revisions to prevailing labor rates provided by the Secretary of Labor. The option provision may be exercised more than once,
but the total extension of performance hereunder shall not exceed 6 months. The Contracting Officer may exercise the option by
written notice to the Contractor within 15 days.

 

(End of Clause)

 

C.3 52.217-9 OPTION TO EXTEND OF THE CONTRACT (MAR. 2000)

 

(a) The Government may extend the term
of this contract by written notice to the Contractor within 15 days; provided that the Government gives the Contractor a preliminary
written notice of its intent to extend at least 30 days days before the contract expires. The preliminary notice does not commit
the Government to an extension.

 

(b) If the Government exercises this option,
the extended contract shall be considered to include this option clause.

 

(c) The total duration of this contract,
including the exercise of any options under this clause, shall not exceed 5 years.

 

(End of Clause)

 

C.4 52.237-3 CONTINUITY OF SERVICES (JAN 1991)

 

(a) The Contractor recognizes that the
services under this contract are vital to the Government and must be continued without interruption and that, upon contract expiration,
a successor, either the Government or another contractor, may continue them. The Contractor agrees to (1) furnish phase-in training
and (2) exercise its best efforts and cooperation to effect an orderly and efficient transition to a successor.

 

(b) The Contractor shall, upon the Contracting
Officer’s written notice, (1) furnish phase-in, phase-out services for up to 90 days after this contract expires and (2)
negotiate in good faith a plan with a successor to determine the nature and extent of phase-in, phase-out services required. The
plan shall specify a training program and a date for transferring responsibilities for each division of work described in the
plan, and shall be subject to the Contracting Officer’s approval. The Contractor shall provide sufficient experienced personnel
during the phase-in, phase-out period to ensure that the services called for by this contract are maintained at the required level
of proficiency.

 

(c) The Contractor shall allow as many
personnel as practicable to remain on the job to help the successor maintain the continuity and consistency of the services required
by this contract. The Contractor also shall disclose necessary personnel records and allow the successor to conduct on-site interviews
with these employees. If selected employees are agreeable to the change, the Contractor shall release them at a mutually agreeable
date and negotiate transfer of their earned fringe benefits to the successor.

 

(d) The Contractor shall be reimbursed
for all reasonable phase-in, phase-out costs (i.e., costs incurred within the agreed period after contract expiration that result
from phase-in, phase-out operations) and a fee (profit) not to exceed a pro rata portion of the fee (profit) under this contract.

 

(End of Clause)

 

    	 	14	 

     

    

 

C.5 VAAR 852.203-70 COMMERCIAL ADVERTISING (JAN 2008)

 

The bidder or offeror agrees that if a
contract is awarded to him/her, as a result of this solicitation, he/she will not advertise the award of the contract in his/her
commercial advertising in such a manner as to state or imply that the Department of Veterans Affairs endorses a product, project
or commercial line of endeavor.

 

(End of Clause)

 

C.6 VAAR 852.211-70 SERVICE DATA MANUALS (NOV l984) 

 

(a) The successful bidder will supply
operation/maintenance (service data) manuals with each piece of equipment in the quantity specified in the solicitation and resulting
purchase order. As a minimum, the manual(s) shall be bound and equivalent to the manual(s) provided the manufacturer’s designated
field service representative as well as comply with all the requirements in paragraphs (b) through (i) of this clause. Sections,
headings and section sequence identified in (b) through (i) of this clause are typical and may vary between manufacturers. Variances
in the sections, headings and section sequence, however, do not relieve the manufacturer of his/her responsibility in supplying
the technical data called for therein.

 

(b) Title Page and Front Matter.
The title page shall include the equipment nomenclature, model number, effective date of the manual and the manufacturer’s
name and address. If the manual applies to a particular version of the equipment only, the title page shall also list that equipment’s
serial number. Front matter shall consist of the Table of Contents, List of Tables, List of Illustrations and a frontispiece (photograph
or line drawing) depicting the equipment.

 

(c) Section 1, General Description.
This section shall provide a generalized description of the equipment or devices and shall describe its purpose or intended use.
Included in this section will be a table listing all pertinent equipment specifications, power requirements, environmental limitations
and physical dimensions.

 

(d) Section II, Installation. Section
II shall provide pertinent installation information. It shall list all input and output connectors using applicable reference
designators and functional names as they appear on the equipment. Included in this listing will be a brief description of the
function of each connector along with the connector type. Instructions shall be provided as to the recommended method of repacking
the equipment for shipment (packing material, labeling, etc.).

 

(e) Section III, Operation. Section
III will fully describe the operation of the equipment and shall include a listing of each control with a brief description of
its function and step-by-step procedures for each operating mode. Procedures will use the control(s) nomenclature as it appears
on the equipment and will be keyed to one or more illustrations of the equipment. Operating procedures will include any preoperational
checks, calibration adjustments and operation tests. Notes, cautions and warnings shall be set off from the text body so they
may easily be recognizable and will draw the attention of the reader. Illustrations should be used wherever possible depicting
equipment connections for test, calibration, patient monitoring and measurements. For large, complex and/or highly versatile equipment
capable of many operating modes and in other instances where the Operation Section is quite large, operational information may
be bound separately in the form of an Operators Manual. The providing of a separate Operators manual does not relieve the supplier
of his responsibility for providing the minimum acceptable maintenance data specified herein. When applicable, flow charts and
narrative descriptions of software shall be provided. If programming is either built-in and/or user modifiable, a complete software
listing shall be supplied. Equipment items with software packages shall also include diagnostic routines and sample outputs. Submission
information shall be given in the Maintenance Section to identify equipment malfunctions that are software related.

 

(f) Section IV, Principles of Operation.
This section shall describe in narrative form the principles of operation of the equipment. Circuitry shall be discussed in sufficient
detail to be understood by technicians and engineers who possess a working knowledge of electronics and a general familiarity
with the overall application of the devices. The circuit descriptions should start at the overall equipment level and proceed
to more detailed circuit descriptions. The overall description shall be keyed to a functional block diagram of the equipment.
Circuit descriptions shall be keyed to schematic diagrams discussed in paragraph (i) below. It is recommended that for complex
or special circuits, simplified schematics should be included in this section.

 

    	 	15	 

     

    

 

(g) Section V, Maintenance. The
maintenance section shall contain a list of recommended test equipment, special tools, preventive maintenance instructions and
corrective information. The list of test equipment shall be that recommended by the manufacturer and shall be designated by manufacturer
and model number. Special tools are those items not commercially available or those that are designed specifically for the equipment
being supplied. Sufficient data will be provided to enable their purchase by the Department of Veterans Affairs. Preventive maintenance
instructions shall consist of those recommended by the manufacturer to preclude unnecessary failures. Procedures and the recommended
frequency of performance shall be included for visual inspection, cleaning, lubricating, mechanical adjustments and circuit calibration.
Corrective maintenance shall consist of the data necessary to troubleshoot and rectify a problem and shall include procedures
for realigning and testing the equipment. Troubleshooting shall include either a list of test points with the applicable voltage
levels or waveforms that would be present under a certain prescribed set of conditions, a troubleshooting chart listing the symptom,
probable cause and remedy, or a narrative containing sufficient data to enable a test technician or electronics engineer to determine
and locate the probable cause of malfunction. Data shall also be provided describing the preferred method of repairing or replacing
discrete components mounted on printed circuit boards or located in areas where special steps must be followed to disassemble
the equipment. Procedures shall be included to realign and test the equipment at the completion of repairs and to restore it to
its original operating condition. These procedures shall be supported by the necessary waveforms and voltage levels, and data
for selecting matched components. Diagrams, either photographic or line, shall show the location of printed circuit board mounted
components.

 

(h) Section VI, Replacement Parts List.
The replacement parts list shall list, in alphanumeric order, all electrical/electronic, mechanical and pneumatic components,
their description, value and tolerance, true manufacturer and manufacturers’ part number.

 

(i) Section VII, Drawings. Wiring
and schematic diagrams shall be included. The drawings will depict the circuitry using standard symbols and shall include the
reference designations and component values or type designators. Drawings shall be clear and legible and shall not be engineering
or productions sketches.

 

(End of Clause)

 

C.7 VAR 852.211-73 BRAND NAME OR EQUAL (JAN 2008)

 

(Note: as used in this clause, the term
“brand name” includes identification of products by make and model.)

 

(a) If items called for by this invitation
for bids have been identified in the schedule by a “brand name or equal” description, such identification is intended
to be descriptive, but not restrictive, and is to indicate the quality and characteristics of products that will be satisfactory.
Bids offering “equal” products (including products of the brand name manufacturer other than the one described by
brand name) will be considered for award if such products are clearly identified in the bids and are determined by the Government
to meet fully the salient characteristics requirements listed in the invitation.

 

(b) Unless the bidder clearly indicates
in the bid that the bidder is offering an “equal” product, the bid shall be considered as offering a brand name product
referenced in the invitation for bids.

 

(c)(1) If the bidder proposes to furnish
an “equal” product, the brand name, if any, of the product to be furnished shall be inserted in the space provided
in the invitation for bids, or such product shall be otherwise clearly identified in the bid. The evaluation of bids and the determination
as to equality of the product offered shall be the responsibility of the Government and will be based on information furnished
by the bidder or identified in his/her bid as well as other information reasonably available to the purchasing activity. CAUTION
TO BIDDERS. The purchasing activity is not responsible for locating or securing any information that is not identified in the
bid and reasonably available to the purchasing activity. Accordingly, to insure that sufficient information is available, the
bidder must furnish as a part of his/her bid all descriptive material (such as cuts, illustrations, drawings or other information)
necessary for the purchasing activity to:

 

(i) Determine whether the product offered
meets the salient characteristics requirement of the Invitation for Bids, and

 

(ii) Establish exactly what the bidder
proposes to furnish and what the Government would be binding itself to purchase by making an award. The information furnished
may include specific references to information previously furnished or to information otherwise available to the purchasing activity.

 

    	 	16	 

     

    

 

(2) If the bidder proposes to modify a
product so as to make it conform to the requirements of the Invitation for Bids, he/she shall:

 

(i) Include in his/her bid a clear description
of such proposed modifications, and

 

(ii) Clearly mark any descriptive material
to show the proposed modifications.

 

(3) Modifications proposed after bid opening
to make a product conform to a brand name product referenced in the Invitation for Bids will not be considered.

 

(End of Clause)

 

C.8 VAAR 852.237-70 CONTRACTOR
RESPONSIBILITIES (APR. 1984)

 

The contractor shall obtain all necessary
licenses and/or permits required to perform this work. He/she shall take all reasonable precautions necessary to protect persons
and property from injury or damage during the performance of this contract. He/she shall be responsible for any injury to himself/herself,
his/her employees, as well as for any damage to personal or public property that occurs during the performance of this contract
that is caused by his/her employees fault or negligence, and shall maintain personal liability and property damage insurance having
coverage for a limit as required by the laws of the State of AK, WA, OR & ID. Further, it is agreed that any negligence of
the Government, its officers, agents, servants and employees, shall not be the responsibility of the contractor hereunder with
the regard to any claims, loss, damage, injury, and liability resulting there from.

 

(End of Clause)

 

C.9 VAAR 852.246-70 GUARANTEE
(JAN 2008)

 

The contractor guarantees the equipment
against defective material, workmanship and performance for a period of 12 months, said guarantee to run from date of acceptance
of the equipment by the Government. The contractor agrees to furnish, without cost to the Government, replacement of all parts
and material that are found to be defective during the guarantee period. Replacement of material and parts will be furnished to
the Government at the point of installation, if installation is within the continental United States, or f.o.b. the continental
U.S. port to be designated by the contracting officer if installation is outside of the continental United States. Cost of installation
of replacement material and parts shall be borne by the contractor.

 

(End of Clause)

 

C.10 VAAR 852,246-71
INSPECTION (JAN 2008)

 

Rejected goods will be held subject to
contractors order for not more than 15 days, after which the rejected merchandise will be returned to the contractor’s address
at his/her risk and expense. Expenses incident to the examination and testing of materials or supplies that have been rejected
will be charged to the contractor’s account.

 

(End of Clause)

 

    	 	17	 

     

    

 

C.11 Notice: Mandatory Electronic Invoicing

 

VA published the final rule requiring
vendors to submit invoices electronically to the Financial Services Center (FSC) in the November 27, 2012 Federal Register. The
rule became effective December 27, 2012. The rule includes a new contract clause to be inserted in all solicitations and contracts
by the contracting officer (VAAR 852.232-72). Vendors can comply with the rule by using either of the two methods below:

 

1.       The FSC uses a
third-party contractor, OB10, to transition vendors from paper to electronic invoice submission. For information on OB10 electronic
invoicing set-up, vendors should call 877-752-0900, or email USClientServices@ob10.com.

 

2.       A system that conforms
to the X12 electronic data interchange (EDI) format established by the Accredited Standards Center. For FSC e-Invoicing information,
please call 877-353-9791 or email vafsccshd@va.gov.

 

FSC and VA’s Office of Acquisition, Logistics and Construction
(OALC) will assist existing commercial vendors in migrating to the electronic process. Until the transition to electronic format
is complete, FSC will continue to process paper invoices for commercial vendors.

 

The FSC’s electronic invoicing system provides a variety
of flexible solutions for all vendor types, including small businesses, and does not require any vendor transaction fees. More
information on the FSC electronic invoicing process can be found at http://www.fsc.va.gov/einvoice.asp.

 

-----END-----

 

    	 	18	 

     

    

 

 

	AMENDMENT
    OF SOLICITATION/MODIFICATION OF CONTRACT	BPA
    NO	1
    CONTRACT ID CODE	PAGE

        1
	OF PAGES

        1

	2 AMENDMENT/MODIFICATION

    NUMBER	3
    EFFECTIVE DATE	4
    REQUISITION PURCHASE REQ NUMBER	5
    PROJECT NUMBER (if applicable)
	P00006	08-01-2018	 	 
	6 ISSUED BY 	CODE	003B6B	7
    ADMINISTERED BY (If other than Item 6) 	CODE	003B6B
	 

        Department of Veterans Affairs

        OPAL / National Acquisition Center

        Building 37

        1st Avenue, One Block North of Cermak

        Hines IL 60141
	 	 

        Department of Veterans Affairs

        OPAL / National Acquisition Center

        Building 37

        1st Avenue, One Block North of Cermak

        Hines IL 60141
	 

	8
    NAME AND ADDRESS OF CONTRACTOR    (Number, street, county, State and ZIP Code)	x	9A
    AMENDMENT OF SOLICITATION NUMBER
	ITAMAR MEDICAL, INC.	 	9B
    DATED (SEE ITEM 11)
	3290 Cumberland Club Dr Ste 100

        Atlanta GA 30339
	x	10A MODIFICATION OF CONTRACT/ORDER NUMBER

        V797D-30190

	 	 	10B
    DATED (SEE ITEM 13)
	code
    6BU26	FACILITY
    CODE	 	06-15-2013

	11.
    THIS ITEM ONLY APPLIES TO AMENDMENTS OF SOLICITATIONS
	 ̈
        The above numbered solicitation is amended as set forth in Item 14. The hour and date specified for receipt of
        Offers           ̈ is
        extended,   ̈ is not extended. Offers must acknowledge receipt
        of this amendment prior to the hour and date specified in the solicitation or as amended, by one of the following methods:
        (a) By completing Items 8 and 15, and returning _________ copies of the amendment; (b) By acknowledging receipt of
        this amendment on each copy of the offer submitted; or (c) By separate letter or electronic communication which includes
        a reference to the solicitation and amendment numbers. FAILURE OF YOUR ACKNOWLEDGMENT TO BE RECEIVED AT THE PLACE DESIGNATED
        FOR THE RECEIPT OF OFFERS PRIOR TO THE HOUR AND DATE SPECIFIED MAY RESULT IN REJECTION OF YOUR OFFER. If by virtue of
        this amendment you desire to change an offer already submitted, such change may be made by letter or electronic communication,
        provided each letter or electronic communication makes reference to the solicitation and this amendment, and is received
        prior to the opening hour and date specified.

	12 ACCOUNTING
    AND APPROPRIATION DATA    (If required)
	13. THIS ITEM APPLIES ONLY TO MODIFICATIONS
        OF CONTRACTS/ORDERS,

        IT MODIFIES THE CONTRACT/ORDER NO.
        AS DESCRIBED IN ITEM 14.

	CHECK

        ONE
	A
    THIS CHANGE ORDER IS ISSUED PURSUANT TO (Specify authority) THE CHANGES SET FORTH IN ITEM 14 ARE MADE IN THE CONTRACT ORDER
    NO IN ITEM 10A
	 	 
	 	B
    THE ABOVE NUMBERED CONTRACT/ORDER IS MODIFIED TO REFLECT THE ADMINISTRATIVE CHANGES SET FORTH IN ITEM 14, PURSUANT TO THE
    AUTHORITY OF FAR 43 103(b)	(such
    as changes in paying office, appropriation date, etc) 
	x	C
    THIS SUPPLEMENTAL AGREEMENT IS ENTERED INTO PURSUANT TO AUTHORITY OF 	AS1508 Option to Extend the Terms of Contract (MAR 2005)

        52.212-4(c) Changes (JAN 2017)

	 	D.
    OTHER (Specify type of modification and authority)

	E. IMPORTANT:
    Contractor    ̈ is
    not,  x is
    required to sign this document and return      1        copies
    to the issuing office.
	14
    DESCRIPTION OF AMENDMENT/MODIFICATION   (Organized by UCF section headings including solicitation/contract subject
    matter where feasible)
	65IIA - Medical Equipment and Supplies
        CONTRACT EXTENSION

        This bilateral modification is used to exercise the Government's
        Option to Extend the performance period of the above FSS contract. The contract expiration date is hereby extended to
        June 14, 2023. The period is now June 15, 2013 through June 14, 2023. No further extensions will be granted. The 10-year
        estimated contract value has changed from $7,700,000 to $17,500,000; an increase of $9,800,000. The Quantity Discount
        percentages % have changed from 3%, 5%, and 10% (with varying thresholds) to NONE. Lastly, the Annual Rebate was changed
        from NONE to 2.5% on all sales made under this contract. The annual rebate percentage shall be applied at the end of each
        rebate year (July 01 - June 30) and each subsequent year thereafter until contract expiration 6/14/2023.

        The contractor is required to update any electronic data
        systems and publish an approved pricelist supplement.

        All other terms and conditions remain
        unchanged and in full effect.

	 
	Except as provided herein,
    all terms and conditions of the document referenced in Item 9A or 10A as heretofore changed, remains unchanged and in full
    force and effect

 

	15A NAME AND TITLE OF SIGNER      (Type
        or print)

         

        Roy Arieli - Director of Operations
	16A. NAME AND TITLE OF CONTRACTING OFFICER      
        (Type or print)

        Monee A. Robinson

        Contracting Officer

	15B CONTRACTOR/OFFEROR
    	15C
    DATE SIGNED	16B
    UNITED STATES OF AMERICA  	16C
    DATE SIGNED
	/s/
    Roy Arieli	7/27/2018	BY	/s/
    Monee A. Robinson  	7/27/2018
	(Signature
    of person authorized to sign)	(Signature
    of Contracting Officer)

 

    	 	 	 

     

    

   

	AMENDMENT
    OF SOLICITATION/MODIFICATION OF CONTRACT	BPA
    NO.	1.
    CONTRACT ID CODE          	PAGE

    1	OF
    PAGES

    2

	2. AMENDMENT/MODIFICATION NUMBER	3. EFFECTIVE
    DATE	4. REQUISITION/PURCHASE
    REQ. NUMBER	5.
    PROJECT NUMBER (if applicable)
	P00009	10-15-2018	 	18-4073
	6. ISSUED BY 	CODE	003B6B	7. ADMINISTERED BY (If other than
    Item 6) 	CODE	003B6B
	Department of Veterans Affairs

        OPAL / National Acquisition Center

        Building 37

        1st Avenue, One Block North of Cermak

        Hines IL 60141
	Department of Veterans Affairs

        OPAL / National Acquisition Center

        Building 37

        1st Avenue, One Block North of Cermak

        Hines IL 60141
	 

	8.
    NAME AND ADDRESS OF CONTRACTOR    (Number, street, county, State and ZIP Code)	x	9A.
    AMENDMENT OF SOLICITATION NUMBER
	ITAMAR MEDICAL, INC.

        (FOREIGN PARENT IS ITAMAR MEDICAL LIMITED, CAESAREA,
        ISRAEL.
	 	9B.
    DATED (SEE ITEM 11)
	3290 Cumberland Club Dr Ste 100

         

        Atlanta GA 30339
	x	10A. MODIFICATION OF CONTRACT/ORDER NUMBER

        V797D-30190

	 	 	10B.
    DATED (SEE ITEM 13)
	code   6BU26	FACILITY
    CODE	 	06-15-2013

	11.
    THIS ITEM ONLY APPLIES TO AMENDMENTS OF SOLICITATIONS
	 ̈
        The above numbered solicitation is amended as set forth in Item 14. The hour and date specified for receipt of
        Offers           ̈ is
        extended,   ̈ is not extended.

            Offers must
        acknowledge receipt of this amendment prior to the hour and date specified in the solicitation or as amended, by one of
        the following methods: (a) By completing Items 8 and 15, and returning _________ copies of the amendment; (b) By
        acknowledging receipt of this amendment on each copy of the offer submitted; or (c) By separate letter or electronic communication
        which includes a reference to the solicitation and amendment numbers. FAILURE OF YOUR ACKNOWLEDGMENT TO BE RECEIVED AT
        THE PLACE DESIGNATED FOR THE RECEIPT OF OFFERS PRIOR TO THE HOUR AND DATE SPECIFIED MAY RESULT IN REJECTION OF YOUR OFFER.
        If by virtue of this amendment you desire to change an offer already submitted, such change may be made by letter or electronic
        communication, provided each letter or electronic communication makes reference to the solicitation and this amendment,
        and is received prior to the opening hour and date specified.

	12. ACCOUNTING
    AND APPROPRIATION DATA    (If required)
	13. THIS ITEM APPLIES ONLY TO
        MODIFICATIONS OF CONTRACTS/ORDERS,

        IT MODIFIES THE CONTRACT/ORDER
        NO. AS DESCRIBED IN ITEM 14.

	CHECK

        ONE
	A.
    THIS CHANGE ORDER IS ISSUED PURSUANT TO: (Specify authority) THE CHANGES SET FORTH IN ITEM 14 ARE MADE IN THE CONTRACT ORDER
    NO. IN ITEM 10A.
	 	 
	 	B.
    THE ABOVE NUMBERED CONTRACT/ORDER IS MODIFIED TO REFLECT THE ADMINISTRATIVE CHANGES SET FORTH IN ITEM 14, PURSUANT TO THE
    AUTHORITY OF FAR 43.103(b).	(such
    as changes in paying office, appropriation date, etc.) 
	 	C.
    THIS SUPPLEMENTAL AGREEMENT IS ENTERED INTO PURSUANT TO AUTHORITY OF: 
	x	D.
    OTHER (Specify type of modification and authority)	552.238.81
    Modification (Federal Supply Schedule), Alternative I, Tailored

 

	E. IMPORTANT:
    Contractor   x is not,   ̈ is
    required to sign this document and return      0        copies
    to the issuing office.
	14.
    DESCRIPTION OF AMENDMENT/MODIFICATION   (Organized by UCF section headings, including solicitation/contract subject
    matter where feasible.)
	65 II A - Product Deletion

         

        This unilateral modification is issued to incorporate
        a product deletion into the above mentioned FSS contract. See "All Commodities-Product Deletion", page 3 for
        deletion details

         

        The contractor is required to
        submit an updated pricelist to the assigned contract specialist within 30 days of the effective date shown in Block
        3. Contractor shall also update GSA Advantage SIP files and product /pricing details that are reflected in the VA's
        Contract Catalog Search Tool within 30 days of the effective date shown in Block 3. All other terms and conditions remain
        unchamged.

 

	Except as provided herein,
    all terms and conditions of the document referenced in Item 9A or 10A, as heretofore changed, remains unchanged and in full
    force and effect.

 

	15A. NAME AND TITLE OF SIGNER      (Type
        or print)

         

        Roy Arieli, Director of Operations
	16A. NAME AND TITLE OF CONTRACTING OFFICER        
        (Type or print)

        Thomas T. Pettis

        Contracting Officer
	Digitally Signed by

        Thomas T. Pettis

        905278

	15B
    CONTRACTOR/OFFEROR 	15C
    DATE SIGNED	16B.
    UNITED STATES OF AMERICA  	16C.
    DATE SIGNED
	/s/
    Roy Arieli	10/12/2018	BY	/s/
    Thomas T. Pettis 905278	Date:
    2018.10.12

    2:50:09-05’00’
	(Signature
    of person authorized to sign)	 	(Signature
    of Contracting Officer)

 

	PREVIOUS EDITION NOT USABLE	STANDARD FORM 30 (REV. 11/2016)
	 	Prescribed by GSA - FAR (48 CFR) 53.243

 

     

     

    

 

Itamar Medical, Inc.

V797D-30190

Log #P00009 - TK #18-4073

Page 2 of 3

 

Incorporate product deletion.

 

The awarded line items and Net
FSS prices are shown on “All Commodities-Product Deletion”.

 

In the event that the identified
TC’s contract/agreement has been cancelled, terminated, expired, or the TC has merged with another group, the contracting
officer shall be notified within 10 days after the event occurs, and if possible, before the event occurs.

 

This modification action is effective October 15,
2018 and is contingent upon the vendor signing and returning one (1) copy prior to the effective date of this modification.
Failure to sign and return a complete copy of this modification will delay the effective date. Additionally, the contractor is
reminded of the following requirements:

 

	 	1.	Publish and distribute an approved pricelist
    supplement.

	 	2.	Update the NAC Contract Management database. The electronic spreadsheet
    may follow via email.

	 	3.	Update GSA Advantage.

 

The contractor is required to amend the current published
Federal Supply Schedule (FSS) price list to reflect the changes to the contract per this modification by means of a Supplemental
FSS Price List. This supplemental price list shall contain the effective date, modification number, reason and the same information
as the initial FSS price list cover sheet. Provide this office with one (1) copy no later than 30 days after receipt of this fully
executed modification.

 

Contract number or other authorizations for supplies
or services performed (including order number and contract line number) must be shown on the invoice. In addition, all correspondence
and documents pertaining to the contract shall be noted with the contract number.

 

All other contract terms and conditions
remain the same as previously awarded.

 

End of Modification

 

     

     

    

 

	SIN#	 	Item
    #	 	Product
    Name / Description	 	Reason
    for Deletion
	A-50H	 	AC20002XX	 	Integrated Sensor	 	No longer sell this item - these parts are no
    longer necessary.
	A-50H	 	AS0060520	 	Oximeter Sensor for WP 200	 	No longer sell this item - these parts are no
    longer necessary.
	A-50H	 	AC20001XX	 	Adhesives Set for Sensor	 	Comparable item being submitted.

 

	All Commodities - Product Deletions	1 of 22

 

      

     

    

  

	AMENDMENT
    OF SOLICITATION/MODIFICATION OF CONTRACT	BPA
    NO.	1.
    CONTRACT ID CODE          	PAGE

    1	OF
    PAGES

    3

	2. AMENDMENT/MODIFICATION NUMBER	3. EFFECTIVE
    DATE	4. REQUISITION/PURCHASE
    REQ. NUMBER	5.
    PROJECT NUMBER (if applicable)
	P00010	12-01-2018	 	19-1135
    (ttp)
	6. ISSUED BY 	CODE	003B6B	7. ADMINISTERED BY (If other than
    Item 6) 	CODE	003B6B
	Department of Veterans Affairs

        OPAL / National Acquisition Center

        Building 37

        1st Avenue, One Block North of Cermak

        Hines IL 60141
	Department of Veterans Affairs

        OPAL / National Acquisition Center

        Building 37

        1st Avenue, One Block North of Cermak

        Hines IL 60141
	 

	8.
    NAME AND ADDRESS OF CONTRACTOR    (Number, street, county, State and ZIP Code)	(x)	9A.
    AMENDMENT OF SOLICITATION NUMBER
	ITAMAR MEDICAL, INC.

        (FOREIGN PARENT IS ITAMAR MEDICAL LIMITED, CAESAREA,
        ISRAEL.
	 ̈  	9B.
    DATED (SEE ITEM 11)
	3290 Cumberland Club Dr Ste 100

         

        Atlanta GA 30339
	x	10A. MODIFICATION OF CONTRACT/ORDER NUMBER

        V797D–30190

	 	 	10B.
    DATED (SEE ITEM 13)
	code   6BU26	FACILITY
    CODE	 	06/15/2013

	11.
    THIS ITEM ONLY APPLIES TO AMENDMENTS OF SOLICITATIONS
	 ̈
        The above numbered solicitation is amended as set forth in Item 14. The hour and date specified for receipt of
        Offers           ̈ is
        extended,   ̈ is not extended.

            Offers must
        acknowledge receipt of this amendment prior to the hour and date specified in the solicitation or as amended, by one of
        the following methods:

           (a) By completing Items 8 and 15, and returning _________ copies of the amendment; (b) By
        acknowledging receipt of this amendment on each copy of the offer submitted; or (c) By separate letter or electronic communication
        which includes a reference to the solicitation and amendment numbers. FAILURE OF YOUR ACKNOWLEDGMENT TO BE RECEIVED AT
        THE PLACE DESIGNATED FOR THE RECEIPT OF OFFERS PRIOR TO THE HOUR AND DATE SPECIFIED MAY RESULT IN REJECTION OF YOUR OFFER.
        If by virtue of this amendment you desire to change an offer already submitted, such change may be made by letter or electronic
        communication, provided each letter or electronic communication makes reference to the solicitation and this amendment,
        and is received prior to the opening hour and date specified.

	12. ACCOUNTING
    AND APPROPRIATION DATA    (If required)
	13. THIS ITEM APPLIES ONLY TO
        MODIFICATIONS OF CONTRACTS/ORDERS,

        IT MODIFIES THE CONTRACT/ORDER
        NO. AS DESCRIBED IN ITEM 14.

	
        CHECK

        ONE

        
	A. THIS CHANGE ORDER IS ISSUED PURSUANT TO: (Specify authority) THE CHANGES SET FORTH IN ITEM 14 ARE MADE IN THE CONTRACT ORDER NO. IN ITEM 10A.
	 ̈

	 
	 ̈	B. THE ABOVE NUMBERED CONTRACT/ORDER IS MODIFIED TO REFLECT THE ADMINISTRATIVE CHANGES SET FORTH IN ITEM 14, PURSUANT TO THE AUTHORITY OF FAR 43.103(b).	(such as changes in paying office, appropriation date, etc.) 
	x	C. THIS SUPPLEMENTAL AGREEMENT IS ENTERED INTO PURSUANT TO AUTHORITY OF: 	552.238.81
    Modification (Federal Supply Schedule), (Apr 2014) (Alternative I, Tailored)
	 ̈	D. OTHER (Specify type of modification and authority)	

 

	E.
    IMPORTANT: Contractor     ̈ is
    not,    x  is
    required to sign this document and return      1        copies
    to the issuing office.
	14.
    DESCRIPTION OF AMENDMENT/MODIFICATION   (Organized by UCF section headings, including solicitation/contract subject
    matter where feasible.)
	65IIA
                                         - Product Addition - SIN A-50(h) -- Physiological Monitors - Others

         

        This bilateral modification is issued to incorporate
        five (5) line items into the above-referenced FSS contract.

        See pages         2-3         for details and a list of products to
        be          added.

         

        All other contract terms and
        conditions remains the same as previously awarded.

 

	Except as provided herein,
    all terms and conditions of the document referenced in Item 9A or 10A, as heretofore changed, remains unchanged and in full
    force and effect.

 

	15A. NAME AND TITLE OF SIGNER      (Type
        or print)

         

        Roy Arieli, Director of Operations
	16A. NAME AND TITLE OF CONTRACTING OFFICER         

        Monee A. Robinson

        Contracting Officer
	(Type or print)

	15B.
    CONTRACTOR/OFFEROR 	15C.
    DATE SIGNED	16B.
    UNITED STATES OF AMERICA  	16C.
    DATE SIGNED
	/s/
    Roy Arieli	11/30/2018			
	(Signature
    of person authorized to sign)	 	(Signature
    of Contracting Officer)

 

	PREVIOUS EDITION NOT USABLE	STANDARD FORM 30 (REV. 11/2016)
	 	Prescribed by GSA - FAR (48 CFR) 53.243

 

      

     

    

 

Itamar Medical, Inc.

V797D-30190

Log #P00010 - TK #19-1135

Page 2 of 3

 

Incorporate product additions.

 

The awarded line items and prices are shown
on “All Commodities - Product Additions - Awarded Pricing”.

 

Kaiser Permanente is the identified Tracking Customer.
During the course of this contract for any sales under the maximum order for all product additions, the established 1.00 ratio
between the Government and the Tracking Customer shall be maintained.

 

In the event that the identified TC’s contract/agreement has
been cancelled, terminated, expired, or the TC has merged with another group, the contracting officer shall be notified within
10 days after the event occurs, and if possible, before the event occurs.

 

Utilization of Dealers/ Distributors by Manufacturers

 

Itamar Medical, Inc. has elected to participate
in marketing the offered products through dealer/dealers/distributors/specialty distributors. This entity is hereby identified
as:

 

Address:        Veterans Healthcare
Supply Solutions

(VHSS) 13949 Alvarez Road

Suite 300

Jackson, FL 32218

 

POC:             Gary Skura

gskura@vhss1.com

(904)
638-5519

 

Trade-In Option

 

For item #CS2110500 – “WatchPat 200
Trade in” Itamar Medical, Inc. has provided the following term:

 

“For the new proposed item called
the WatchPat 200 trade-in, Itamar will accept a Government Agency trading in any sleep testing device of any other company.”

 

The Government accepts this new term as proposed and will incorporate
it into the aforementioned contract.

 

      

     

    

 

This modification action is effective December 01, 2018 and
is contingent upon the vendor signing and returning one (1) copy prior to the effective date of this modification. Failure to sign
and return a complete copy of this modification will delay the effective date. Additionally, the contractor is reminded of the
following requirements:

 

		1.	Publish and distribute an approved pricelist supplement.

		2.	Update the NAC Contract Management database. The electronic
spreadsheet may follow via email.

		3.	Update GSA Advantage.

 

The contractor is required to amend the current published Federal
Supply Schedule (FSS) price list to reflect the changes to the contract per this modification by means of a Supplemental FSS Price
List. This supplemental price list shall contain the effective date, modification number, reason and the same information as the
initial FSS price list cover sheet. Provide this office with one (1) copy no later than 30 days after receipt of this fully executed
modification.

 

Contract number or other authorizations for supplies or services
performed (including order number and contract line number) must be shown on the invoice. In addition, all correspondence and documents
pertaining to the contract shall be noted with the contract number.

 

All other contract terms and conditions remain the same as previously
awarded.

 

Awarded Line Items

 

	SIN#	 	Item #	 	Product Name / 
 Description	 	Tracking
 Ratio	 	 	FSS Price
 without IFF	 	 	FSS Price
 with IFF	 	 	Red “A”
	A-50H	 	AC30003XX	 	Central Plus Sensor	 	 	1.00	 	 	$	799.00	 	 	$	803.02	 	 	A
	A-50H	 	AC30001XX	 	Central Plus Replacement	 	 	1.00	 	 	$	325.00	 	 	$	326.63	 	 	A
	A-50H	 	AC20004XX	 	SBP Sensor for WatchPAT	 	 	1.00	 	 	$	200.00	 	 	$	201.01	 	 	A
	A-50H	 	AC2000110	 	Adhesives Set for SBP Sensor	 	 	1.00	 	 	$	15.00	 	 	$	15.08	 	 	A
	A-50H	 	CS2110500	 	WatchPAT 200 Trade In	 	 	1.00	 	 	$	2,000.00	 	 	$	2,010.05	 	 	A

 

This modification action is effective December
1, 2018. All other contract terms and conditions remain in full effect.

 

End of ModificationExhibit 4.6

 

[INFORMAL ENGLISH TRANSLATION]

 

Itamar Medical Ltd.

 

("the Company")

 

Compensation policy (English Translation)

 

As approved by the Company's Compensation
Committee on January 18, 2016;

 

by the Company Board of Directors
on January 21, 2016;

 

by the Company’s Compensation
Committee on March 7, 2016;

 

and by Company’s shareholders
at the General Meeting held on March 16, 2016

 

Definitions and terms used in this compensation policy shall
have the meaning associated with them in the Corporate Act, 1999 (hereinafter: "the Corporate Act"), unless otherwise
defined in the compensation policy.

 

		1.	General

 

On December 12, 2012, Amendment 20 to the Corporate
Act became effective (hereinafter: "the Amendment"), which governs the structure of compensation of officers at
public companies and at debenture companies, and specifies a special process for approval thereof. In conformity with the Amendment,
the Company's Compensation Committee and Board of Directors have adopted this compensation policy.

 

The considerations applied by the Company's Compensation
Committee (hereinafter: "the Compensation Committee") and the Company Board of Directors in adopting this policy
are: promoting the Company's best interests, its work plan and policy in view of the current year as well as from a long-term perspective
considering, inter alia, the Company's risk management policy, aligning the interest of officers with those of Company
shareholders, size and nature of its operations and - with regard to terms of office and employment which include variable components
- the officer's contribution to achieving of the Company's objectives, maximizing its earnings and its valuation, all from the
long-term perspective and in accordance with the officer's role.

 

The compensation policy was compiled with attention
to the nature of the Company, being a Company engaged in research and development, sales and marketing of medical instruments,
with attention to the Company's current scope of operations, to the Company being included in the BioMed Index of the Tel Aviv
Stock Exchange Ltd. (hereinafter: "the Stock Exchange") and with due attention to the Company's strategy of increasing
its business scope in line with the Company's business and strategic plans.

 

     

     

    

 

The principles of the compensation policy were specified
after internal discussions by the Compensation Committee and the by the Company Board of Directors, in consultation with external
advisors. Policy principles were designed to achieve compensation of Company officers, which would ensure that officer compensation
is aligned with the Company's best interests and its overall organizational strategy, with due consideration to the Company's risk
management policy, and would concurrently result in a sense of identification of Company officers with the Company and its operations,
would increase officer satisfaction and motivation and would preserve officers in the Company's service for a long time.

 

The compensation guidelines are based on targets
and benchmarks derived, inter alia, from various Company plans – as determined by the Board of Directors from time
to time.

 

Compensation policy components would refer to each
of the following:

 

		A.	Fixed components: Salary, social benefits (such
as: beneficial retirement arrangement, disability insurance, study fund, paid leave, sick leave and vacation pay) and other benefits
(such as: company car, cell phone, laptop computer, internet connection, attending professional seminars, professional literature,
professional liability insurance, including gross-up of the benefit value for tax purposes) and may include a signing bonus and
relocation bonus as well as payments upon retirement (bonus, payment, compensation or any other benefit offered to an officer
with regard to their departure from the Company).

 

		B.	Variable components: Various bonuses including, inter alia, annual bonus, special bonus etc.

 

		C.	Equity-based variable components: Options, shares, restricted shares, restricted share units etc. allocated in conjunction
with equity-based compensation programs adopted and/or to be adopted by the Company.

 

		D.	Insurance, waiver and indemnification: Board members' and officers' liability insurance (in the normal course of business
as well as for non-recurring events (run-off)), waiver of officers' liability, in advance and in retrospect, and provision of commitment
to indemnify officers in advance and in retrospect.

 

    	 	2	 

     

    

 

Provisions of this compensation policy apply
to Company officers, as defined in the Corporate Act.

 

The compensation policy, although worded in the
masculine for convenience, applies equally to both men and women.

 

Note that whenever this compensation policy refers
to (gross) annual pay / base salary, the actual total cost to the Company would also include payment of social and other benefits
as required by law.

 

Note that this policy foes not confer any rights
on Company officers and Company officers shall not have any vested right due merely to adoption of this compensation policy, to
receive any of the compensation components listed in the compensation policy. The compensation components to which officers would
be eligible are only those individually approved for each officer by the qualified Company organs.

 

		2.	Principles for setting compensation

 

		2.1.	The Company's Compensation Committee and Board of Directors,
when reviewing and approving the terms of office and employment of an officer (including an update to pay of an incumbent officer),
shall refer, inter alia, to the following matters as applicable to the officer:

 

		2.1.1.	The officer's education, qualifications, expertise, professional experience and achievements.

 

		2.1.2.	The officer's roles and responsibilities and their expected contribution to achievement of Company targets.

 

		2.1.3.	Previous pay agreements for the officer.

 

		2.1.4.	Employment terms of similar officers at the Company.

 

		2.1.5.	If needed, at the discretion of the Compensation Committee, a comparison would be conducted with acceptable pay in the relevant
market for similar positions with other companies.

 

    	 	3	 

     

    

 

		3.	Ratio of fixed component to variable component

 

The ratio of maximum annual cost
of fixed components to maximum annual cost of variable components for Company officers, as set forth in this compensation policy,
is as follows:

 

	 	 	Fixed component as
 percentage of total
 compensation (%)	 	 	Variable component
 (bonus and equity) as
 percentage of total
 compensation (%)	 
	Executive Chairman of Board of Directors	 	 	47%-100	%	 	 	0%-53	%
	External and independent Board members	 	 	18%-100	%	 	 	0%-82	%
	Board members other than Executive Chairman of the Board or external / independent Board members	 	 	18%-100	%	 	 	0%-82	%
	CEO	 	 	100%-32	%	 	 	0%-68	%
	Other officer (other than Board member or CEO)	 	 	31%-100	%	 	 	0%-69	%

 

		4.	Fixed component

 

		4.1.	Base salary

 

		4.1.1.	Chairman of the Board of Directors

 

		4.1.1.1.	Total annual compensation for services of the Executive
Chairman of the Board of Directors (gross) payable to the Executive Chairman of the Board of Directors with respect to providing
services to the Company, would be determined by the Compensation Committee, the Company Board of Directors and the General Meeting
of Company shareholders - not to exceed USD 150,000 (at the current exchange rate as it may be from time to time) for a full-time
position. In case of joint office of two Executive Chairmen of the Board of Directors, the aggregate annual compensation (gross)
for services provided by both Executive Chairmen of the Board of Directors shall not exceed the aforementioned amount.

 

    	 	4	 

     

    

 

		4.1.1.2.	The Company may also award
the Executive Chairman of the Board of Directors securities at a fair value as listed in section  ‎6.3
below.

 

		4.1.1.3.	The Company's Compensation
Committee and Board of Directors may approve and submit for approval by the General Meeting of Company shareholders, an annual
update of the total compensation payable to the Executive Chairman of the Board of Directors with respect to providing services
to the Company, provided that such pay increase would not exceed five percent (5%) of the amount set forth in section 
‎4.1.1.1 above, during the entire
term of this compensation policy.

 

		4.1.1.4.	In addition, a Chairman of the Board of Directors (executive
or non-executive) would be eligible for reimbursement of reasonable expenses incurred in the course of their office, against
presentation of receipts, as customary at the Company.

 

		4.1.2.	Board members (other than Executive Chairman of the
Board of Directors)

 

		4.1.2.1.	Compensation of external Board members and independent
Board members of the Company would be relative or annual compensation and compensation per meeting (including in cases of written
resolution or telephone call) as well as expense reimbursement in accordance with provisions of regulations set forth in Corporate
Regulations (Rules for compensation and expense reimbursement for external board members), 2000 (hereinafter: "the External
Board Member Compensation Regulations"), as they may be from time to time.

 

    	 	5	 

     

    

 

		4.1.2.2.	The Company may also award securities to external Board members and to independent Board members,
in conformity with the External Board Member Compensation Regulations at a fair value as set forth in section  ‎6.3
below. 

 

		4.1.2.3.	The Company may pay special compensation to expert Board members, which would be relative or annual compensation and compensation
per meeting (including in cases of written resolution or telephone call) as well as expense reimbursement in accordance with provisions
set forth in the External Board Member Compensation Regulations, as they may be from time to time.

 

		4.1.2.4.	Compensation payable to Board members other than external Board members, independent Board members
and/or Executive Chairman of the Board of Directors (annual compensation and compensation per meeting) shall not exceed the amount
allowed by the External Board Member Compensation Regulations, as they may be from time to time. The Company may also award such
Board members securities at a fair value as listed in section  ‎6.3
below. Total compensation payable to each such Board member (including variable components) shall not exceed the compensation actually
paid to external Board members[1].

 

		4.1.2.5.	Furthermore, Company Board members would be eligible for reimbursement of reasonable expenses incurred in the course of their
office, against presentation of receipts, as customary at the Company.

 

 

 

		1	If
compensation payable to external Board members is not identical, including if one of the external Board members is eligible to
additional pay for being an expert external Board member, then then compensation payable to an ordinary Board member may be equal
to the higher compensation.

 

    	 	6	 

     

    

 

		4.1.3.	Company CEO

 

		4.1.3.1.	Total annual (gross) pay for the Company CEO would be determined by the Compensation Committee, the Company Board of Directors
and the General Meeting of Company shareholders - not to exceed USD 270,000 (at the current exchange rate as it may be from time
to time) for a full-time position.

 

		4.1.3.2.	The Company's Compensation Committee and Board of Directors
may approve and submit for approval by the General Meeting of Company shareholders, subject to statutory provisions, an annual
update of the total annual pay of the Company CEO, provided that such pay increase would not exceed twenty percent (20%) of the
amount set forth in this section above, during the entire term of this compensation policy.

 

		4.1.3.3.	When setting the pay of the Company CEO, members of the
Company's Compensation Committee and Board of Directors may take into consideration, inter alia, the pay of CEOs of other
public companies similar to the Company in size and nature (hereinafter: "the Comparison Companies") as well
as the Company's financial performance and contribution of the CEO to the Company.

 

		4.1.3.4.	Furthermore, the Company CEO would be eligible for reimbursement
of reasonable expenses incurred in the course of their office, against presentation of receipts, as customary at the Company.

 

		4.1.4.	Officers 

 

		4.1.4.1.	Total annual (gross) pay for each Company officer would
be determined by the Company's Compensation Committee and Board of Directors, not to exceed NIS 562,000 for a full-time position.

 

		4.1.4.2.	The Company's Compensation Committee and Board of Directors
may approve an annual update of the total annual pay of Company officers, provided that such pay increase would not exceed twenty
percent (20%) of the amount set forth in this section above, during the entire term of this compensation policy.

 

    	 	7	 

     

    

 

		4.1.4.3.	When setting pay for Company officers, members of the
Company's Compensation Committee and Board of Directors may take into consideration, inter alia, the pay of officers in
similar positions at the Comparison Companies as well as the Company's financial performance and the officer's contribution to
the Company.

 

		4.1.4.4.	Furthermore, Company officers would be eligible for reimbursement
of reasonable expenses incurred in the course of their office, against presentation of receipts, as customary at the Company.

 

		4.2.	Social and other benefits

 

		4.2.1.	The Company may award to officers, other than Board members,
social and other benefits as listed below, to be determined by comparison to generally accepted market terms for officers in similar
positions and in conformity with Company policy, such as: (a) Beneficial retirement arrangement (including optional arrangement
pursuant to Section 14 of the Severance Pay Act, 1963); (b) Disability insurance; (c) Medical insurance; (d) Contributions to
a study fund; (e) Paid leave; (f) Vacation pay; (g) Sick pay; (h) Company car.

 

		4.2.2.	The Company may also award to officers and Board member
other benefits, such as: Cell phone, laptop computer, internet connection etc.

 

		4.3.	Signing bonus and relocation bonus

 

		4.3.1.	The Company may, under circumstances to be classified by
the Company's Compensation Committee and Board of Directors as extraordinary circumstances whereby recruiting said officer is
highly important to the Company, offer the officer a signing bonus or relocation bonus - all subject to obtaining the required
statutory approvals.

 

    	 	8	 

     

    

 

		4.3.2.	The total signing bonus may not exceed 12 months' base
salary as determined for the relevant officer. The Company may determine, upon the award date of the signing bonus at the discretion
of the Compensation Committee and the Board of Directors, that the officer would be required to reimburse the Company for the
signing bonus awarded, in whole or in part, should they fail to complete a minimum term in office with the Company.

 

		4.3.3.	A relocation bonus would be awarded in case where the officer
was relocated to another country for their work with the Company. The total relocation bonus would be calculated based on actual
expenses incurred by the officer with respect to their relocation and against presentation of receipts, but not to exceed USD
90,000 for the Company CEO and USD 50,000 for an officer other than the CEO - which may be payable in cash or in share-based compensation,
at the discretion of the Company's Compensation Committee and Board of Directors.

 

		4.4.	Severance pay

 

In case of termination of employment (other than
in case of termination of an officer for cause, which the Compensation Committee and Board of Directors consider that gives the
Company the right to terminate the officer without payment of severance pay as required by law), the officer would be eligible
to receive severance pay by law or - alternatively - equal to the amount of payments contributed on behalf thereof with respect
to severance pay, to a provident fund, pension fund etc. - in conformity with provisions of section 14 of the Severance Pay Act,
1963, all subject to the Company's discretion and as specified in their employment contract. Notwithstanding the foregoing, the
Company may stipulate in the officer's employment contract (whether upon signing the employment contract or upon revising it) severance
pay in an amount which exceeds the amount payable by law to the officer.

 

		4.5.	Notice period

 

		4.5.1.	The Company may give the Company CEO a notice period of
up to six (6) months. The Company may give a Company officer other than the Company CEO a notice period of up to four (4) months.
The Company may waive employment of the officer during the notice period, in whole or in part, provided that the Company would
pay all amounts payable to the officer pursuant to their employment contract. Alternatively, the Company may terminate the officer
without a notice period, provided that the Company would pay the officer, upon termination thereof, an amount not less than the
payment due, in lieu of the notice period.

 

    	 	9	 

     

    

 

		4.5.2.	The Compensation Committee and the Board of Directors may
confirm that the officer would be entitled to bonus payments, in cash or in equity, with respect to the notice period and that
the notice period would count for vesting of any equity-based compensation awarded there to.

 

		4.5.3.	The notice period for each officer would be stipulated
in their employment contract (whether upon signing the employment contract or upon revising it).

 

		5.	Variable component – bonus, special bonus and
commissions

 

		5.1.	Targets for annual bonus for a Company officer (including
Company CEO, excluding Board members)

 

The Company may award to an officer (including Company
CEO, excluding Board members) an annual bonus, to be calculated pro-rata to their achievement of various targets and benchmarks,
in whole or in part, as follows:

 

		5.1.1.	Company targets – Company benchmarks are economic
benchmarks of Company performance, as follows: (a) Company share price or Company market cap on the stock exchange where traded;
(b) Revenues from Company sales; (c) Operating income/loss2;
(d) Revenues from sales of any Company product; (e) Revenues from sales of Company products, in whole or in part, in a specific
market / territory; (f) Gross earnings/loss; (g) Net earnings/loss; (h) EBITDA. The weighting of Company target(s) selected would
range between 0% - 100%. Targets (b) through (h) above would be calculated based on the Company's audited consolidated financial
statements.

 

 

 

		2	For review of the aforementioned criteria, operating income
/ loss would be taken into account net of depreciation and amortization, changes in provision for doubtful debt and bad debt,
expenses with respect to share-based payment and the effect of non-recurring events.

 

    	 	10	 

     

    

 

		5.1.2.	Individual targets – Benchmarks to be set for each officer, other than the CEO, in conformity with their position
and the Company's work plan: Achievement of development targets; reduction of manufacturing cost; improvement of product quality
as measured by the number of malfunctions; improvement of financial benchmarks at organizational unit level, such as sales and
profitability; achievement of targets for customer installation backlog; penetration of new markets; achievement of sales mix;
cash balances; collection; achievement of expense targets; achievement of financing targets; signing distribution deals; implementation
of distribution deals; customer satisfaction benchmark; employee satisfaction benchmark; target for employee turnover rate; regulatory
filing and approval according to plan; clinical trials and patient recruiting for clinical trials; achievement of number of new
product launches; capital raised (for relevant organizational units); reduction of inventory volume and shorter inventory turnover;
publication of clinical articles according to plan; introduction of Company products into guidelines; achievement of success targets
for customer training and marketing events; achievement of delivery targets; and milestones for obtaining insurance coverage approval.
The weighting of individual target(s) selected would range between 0% - 100%.

 

		5.1.3.	Supervisor evaluation – Performance evaluation by the Company Board of Directors (for the CEO) or by the Company
CEO (for all other officers). This evaluation should refer, inter alia, to non-financial criteria, to the officer's long-term
contribution and to their long-term performance. The weighting assigned to this category is up to 20%.

 

The Compensation Committee and the Board of Directors
shall set the number and composition of targets and the weighting for each target within the same category (for example: If 2 individual
targets are selected, the Board of Directors would set the weighting for each of them, provided that their total weighting may
not exceed 100%) and may set eligibility for compensation to be contingent on achievement of only one target - which may all be
of the same type.

 

    	 	11	 

     

    

 

Details of targets in each measurement category and
the weighting of each measurement category would be adjusted individually for each officer, based on seniority and the organizational
unit managed / assigned to.

 

		5.2.	Date of setting criteria

 

For officers other than the Company CEO, the weighting
of each of the different measurement categories would be set every year in advance, subject to approval by the CEO and the Compensation
Committee. For the Company CEO, the weighting of each of the different measurement categories would be set at least once every
year in advance by the Company Board of Directors, subject to approval by the Compensation Committee. Notwithstanding the foregoing,
such weighting may be set for several years in advance, subject to the relevant organ being authorized to amend the weightings,
if needed, at the start of each calendar year.

 

		5.3.	Maximum annual bonus – The maximum annual bonus amount may not exceed nine (9) monthly base salaries (in cost-to-company
terms) for the Company CEO, six (6) monthly base salaries (in cost-to-company terms) for each other officer (other than a Board
member or CEO) resident in Israel.

 

		5.4.	Payment of the annual bonus – The annual bonus may be paid, in whole or in part, in cash or in share-based compensation
(such as shares, restricted shares, option warrants etc.), at the discretion of the Company's Compensation Committee and Board
of Directors.

 

		5.5.	The annual bonus is payable soon after the Company has final data with regard to the relevant criteria and as for criteria
based on the financial statements – after publication of the Company's audited annual financial statements.

 

		5.6.	Calculation of cash bonus upon termination of employment – In case of termination of the officer's employment
by the Company due to termination of the officer during a calendar year (provided this is not termination for cause): The terminated
officer would be eligible to the pro-rata share of the annual bonus only with respect to achievement of criteria based on the financial
statements, to be calculated according to the following: (a) The period in that calendar year during which the officer served in
their office with the Company; (b) The rate of achievement of the criteria by the Company; (c) The weighting assigned to each criteria.

 

    	 	12	 

     

    

 

		5.7.	In case of termination of the officer's employment by the Company due to resignation of the officer during a calendar year
(provided this is not resignation under circumstances which would have constituted termination for cause had the officer been terminated
by the Company): The officer resigning would be eligible to the annual bonus for a given calendar year, only for achievement of
criteria based on the financial statements and only if they serve as officer of the Company through March 31 of the following year,
with the bonus amount calculated as set forth in sections 5.4 thru 5.6 above.

 

		5.8.	For calculation of equity-based bonus upon termination of employment, see section ‎6.11 below.

 

		5.9.	Special bonus 

 

		5.9.1.	In addition to the annual bonus, the Company may award each officer a special bonus for officer performance which is not measurable
or for outstanding, exceptional contribution by the officer - such as with regard to closing an outstanding transaction in its
size or achievement represented. The special bonus would be awarded to an officer, other than the CEO, based on a recommendation
by the CEO and subject to approval by the Compensation Committee and Board of Directors. As for the Company CEO, a special bonus
may be awarded to them based on recommendations by the Board of Directors and subject to approval by the Compensation Committee,
Board of Directors and General Meeting of Company shareholders.

 

		5.9.2.	A special bonus may only be paid to an officer once per year. The special bonus amount may not exceed three (3) monthly base
salaries (in cost-to-company terms) for each Company officer3.

 

 

 

		3	According to Section 5.1.3 above, 20% of the total annual
bonus to officers of the Company may be granted based on supervisor’s evaluation (the “Annual Bonus Discretionary
Component”), while the total annual bonus shall not exceed 6 monthly salaries (or 9 monthly salaries, for Company’s
CEO), in cost-to-company terms. It is clarified that the Annual Bonus Discretionary Component and the Special Bonus paid to any
officer for the same calendar year shall not exceed, in total, three (3) monthly salaries, in cost-to-company terms, per each
of the Company’s officers.

 

    	 	13	 

     

    

  

		5.9.3.	The special bonus may be paid, in whole or in part, in cash or in share-based compensation (such as shares, restricted shares,
option warrants etc.), at the discretion of the Company's Compensation Committee and Board of Directors.

 

		5.10.	Commissions 

 

		5.10.1.	In addition to the annual bonus and to the special bonus, the Company may pay commissions to officers involved in sales, marketing
and business development - in conformity with Company procedures, as approved by the Company's Compensation Committee and Board
of Directors.

 

		5.10.2.	The amount of commissions awarded to such officer would be calculated as percentage of total Company sales revenues or sales
revenues for any Company product or sales revenues for Company products, in whole or in part, in a specific market / territory,
to be specified in advance in each calendar year for the subsequent year, by the Company's Compensation Committee and Board of
Directors. In any case, total commissions awarded to any officer may not exceed NIS 700,000 per year.

 

		5.11.	Discretion with regard to bonus reduction

 

The Company's Compensation Committee and Board of
Directors may, in exceptional cases and at their discretion, reduce or cancel a bonus or commissions awarded to an officer.

 

		6.	Equity-based variable component

 

		6.1.	General

 

The Company may adopt from time to time plans for
award of options exerciseable into Company shares, plans for award of shares, restricted shares and/or restricted share units etc.
to officers, in order to provide incentive for Company officers to achieve the targets of the annual work plan, or any other target
to be specified by the Company's Compensation Committee and Board of Directors (including target share price or market cap for
the Company on the stock exchange where Company shares are traded) as well as from a long-term Company policy viewpoint - all in
conformity with terms and conditions set forth in this compensation policy below.

 

 

 

Special Bonus paid to any officer
for the same calendar year shall not exceed, in total, three (3) monthly salaries, in cost-to-company terms, per each of the Company’s
officers.

 

    	 	14	 

     

    

  

The Company may award options, shares, restricted
shares and/or restricted share units (in this Section 6: "Securities"), pursuant to employee compensation plans
to be adopted in future or previously adopted by the Company for officers from time to time, based on the education, skills, expertise,
professional experience, position, roles and responsibilities and contribution to the Company of the relevant officer.

 

		6.2.	Award dates of Securities – The securities would be awarded from time to time, at the discretion of the Company
Board of Directors or a Board committee duly authorized and in line with recommendations made by the Compensation Committee, but
no more than twice annually per officer.

 

		6.3.	Fair value – The fair value of securities awarded to each officer as of the award date, in annualized terms, may
not exceed eighteen (18) monthly salaries (in terms of cost) for the Company CEO or six (6) monthly salaries (in terms of cost)
for any officer other than a Board member or CEO4.
Note that the aforementioned fair value caps exclude any annual bonus or special bonus payable by way of equity-based compensation,
which would be subject to the caps listed in sections 5.3 and 5.9 above, respectively.

 

The fair value of securities to be awarded to each
Board member as of the award date, in annualized terms, may not exceed NIS 300,000. Securities may be awarded to Board members
once per year at most.

 

		6.4.	Exercise price – Subject to vesting of options, the option exercise price shall be as follows:

 

		6.4.1.	For service options, which vesting is subject to passage of time (not target based): the exercise price shall not be lower
than the average Company share price on the stock exchange over the thirty (30) trading days preceding the award approval date
by the Company Board of Directors plus 5%.

 

 

 

		4	For the purpose of section 6.3, the fair value of securities
as of the award date, in annualized terms, will be calculated as the result of dividing the economic value to be used for financial
reporting by the number of years for vesting (which differs from recording of accounting expenses, which may differ due to a different
attribution of the economic value over the years).

 

    	 	15	 

     

    

  

		6.4.2.	For options with target based vesting terms: the exercise price shall not be lower than the average Company share price on
the stock exchange over the thirty (30) trading days preceding the award approval date by the Company Board of Directors.

 

Note that unless otherwise specified by the Compensation
Committee and Board of Directors and subject to applicable law (including the Companies Law and the Tel-Aviv Stock Exchange Bylaws),
the exercise price for restricted shares and restricted share units is zero.

 

		6.5.	Eligibility – The Company may award Securities to officers, which would vest after a specified period of time
and subject to continued employment by the Company; the Company may also award Securities to officers, which would vest subject
to achievement of targets and/or milestones and/or upon occurrence of a pre-specified event and subject to continued employment
(or service provision) with the Company and/or with an affiliated company. Notwithstanding the generality of the foregoing, such
targets may include a target share price or market cap for the Company on the stock exchange where Company shares are traded.

 

		6.6.	The vesting period of the Securities shall be as determined by the Company on the award date, but in any case (other than as
stated in section 6.7 below), the vesting period of the first lot of Securities awarded on each award date shall be at least one
year after the award date or after the employment start date of the officer by the Company, as determined by the Company Board
of Directors.

 

		6.7.	Accelerated vesting of Securities

 

The Compensation Committee and
the Board of Directors may specify that upon occurrence of an Acceleration Event (as defined below), or due to termination of the
contract for reason of death or disability, vesting of the Securities awarded to the officer, in whole or in part, would be accelerated
- including with regard to Securities awarded prior to approval of this compensation policy.

 

    	 	16	 

     

    

  

“Acceleration Event”
means one or more of the following events, while the Company shall have the sole discretion to define, with respect to each grant
of Securities, which of the following events shall be deemed an Acceleration Event with respect to the same grant (as long as such
definition includes at least one of the following events): (a) change of control in the Company (as such term is defined in the
securities Law, 1968); (b) sale of all or substantially all of the Company’s assets; (c) the grant of a worldwide exclusive
license to all, or substantially all, of Company’s intellectual property; (d) merger following which the shareholders of
the Company immediately prior to the merger hold less than 50% (or a lower share, as may be determined by the Company’s compensation
committee or the Company’s board of directors) of the outstanding share capital and the voting rights in the entity surviving
the merger; (e) US IPO.

 

		6.8.	Exercise period – The Company may award Securities which may be exercised within a period not to exceed ten (10)
years from the award date (if not previously expired), all as set forth in the allotment plan. Within up to 10 years from the award
date, all un-exercised Securities shall expire.

 

		6.9.	Adjustments - The Securities would be subject to customary price adjustments, including adjustments for dividends, bonus
shares, changes to share capital (split / reverse split etc.), rights issuance and corporate re-structuring (such as: merger /
spin-off etc.)

 

		6.10.	Exercise at benefit value – Subject to obtaining a pre-ruling from the Tax Authority, as needed, the Company's
Compensation Committee and Board of Directors may stipulate in the award of Securities that they would be exercised at their inherent
benefit value ("cash-less exercise").

 

		6.11.	Termination of employment – Upon adopting a plan to award Company Securities, the plan shall refer to conditions
in case of termination of employment of the officer by the Company, including in case of termination by the Company or due to death
or disability of the officer.

 

		6.12.	Maximum dilution rate – the cumulative quantity of Securities granted to company’s employees during the
term commencing upon the approval of this Compensation Policy and ending upon the approval of a new compensation policy (the “Relevant
Term”) shall not exceed 15% of the issued and outstanding share capital of the Company, on a fully diluted basis. If,
at the time of calculation of the maximum dilution rate, there are Securities that already exercised to shares of the Company,
then, with regard to such Securities that were exercised by way of cashless exercise (pursuant to Section 6.10 above), only the
number of the exercise shares actually issued as a result of such cashless exercise will be taken into account in this calculation
(not the number of such convertible Securities prior to their exercise).

 

    	 	17	 

     

    

  

		6.13.	The Company's Compensation Committee and Board of Directors have considered the optional setting of a cap on exercise value
of equity-based variable components and have resolved not to set such a cap in the compensation policy.

 

		7.	Engagement as contractor or through management company

 

The Company may engage the officer as an independent
contractor rather than as a salaried employee. In such case, all caps listed in this document would be converted into terms of
cost to the employer for review whether employment terms of such officer comply with guidelines in this compensation policy - which
would apply to them, mutatis mutandis. In such case, the term "employment contract" used in this policy should
be read as "service provision agreement" or "consulting agreement", as the case may be.

 

		8.	Work overseas

 

Notwithstanding provisions of this compensation policy,
the pay cap for officers residing outside Israel for the purpose of discharging their office overseas, would be in conformity with
acceptable pay for similar officers in the Company or for officers in other public companies similar in size and nature to the
Company, who reside in the same country.

 

		9.	Insurance, waiver and indemnification

 

		9.1.	The Company may award officers liability insurance (including run-off insurance policies), waiver and indemnification commitment,
as customary at the Company, all subject to provisions of the Corporate Act and of Company Bylaws.

 

		9.2.	Notwithstanding the generality of the foregoing, the Company may, at any time during the term of this compensation policy,
obtain a Board member and officer liability insurance policy (including controlling shareholders), as may serve the Company from
time to time, may extend and/or renew such existing insurance policy and/or may contract a new insurance policy upon the renewal
date or during the insurance period, with the same insurer or with another insurer in Israel or overseas, at terms such as listed
below, to cover liability of Board members and/or officers - provided that such contracting would be based on key terms as listed
below and be approved by the Company's Compensation Committee and Board of Directors.

 

    	 	18	 

     

    

  

		9.2.1.	The maximum insurance coverage in the insurance policy shall not exceed USD 50 million claim and on aggregate for the insurance
period;

 

		9.2.2	The maximum annual insurance premium shall not exceed (a) U.S. $150,000 or (b) if, and so long as, the Company is subject to
reporting obligations to the U.S. Securities and Exchange Commission (the "SEC"), the annual premium shall not exceed
U.S. $350,000. The annual ceiling as above may be annually adjusted by up to 10% over the premium in the preceding year;

 

		9.2.3	The Company's Compensation Committee and Board of Directors shall approve annually the Company's
contracting of a new insurance policy in compliance with the terms and conditions set forth in sections 9.2.1 and 9.2.2 above;

 

		9.2.4	The insurance policy shall be extended to cover claims filed against the Company itself (as distinct
from claims filed against Board members and/or officers thereof) concerning violation of securities laws at least in Israel(entity
coverage for securities claims), or if, and so long as, the Company is subject to reporting obligations to the SEC, concerning
violation of securities laws at least in Israel and the U.S., and payment arrangements shall be specified for insurance payouts,
whereby the rights of Board members and/or officers to be indemnified by the insurance in conformity with the previous insurance
policy precede those of the Company;

 

The insurance
policy shall also cover the liability of Board members and officers considered to be controlling shareholders of the Company or
relatives thereof, from time to time, provided the terms of their coverage shall not exceed those of all other Board members or
officers of the Group.

 

		9.2.5	The Company shall be allowed to grant the directors and Office Holders with liability insurance
(including run-off policies) for special events, such as a public offering, sale or a merger of the Company, provided that (a)
the maximum insurance coverage is as described in item 9.2.1; and (b) the premium paid therefor does not exceed U.S. $600,000.

  

		10.	Reimbursement of amounts paid to officers

 

In case where the Company's audited, consolidated
financial statements for any year should be revised so that the bonus amount payable to the officer for that year, had it been
calculated based on the revised data, would have resulted in a different bonus amount payable to the officer, the Company would
pay to the officer, or the officer would reimburse the Company, as the case may be, the difference between the bonus amount paid
and the bonus amount payable due to said revision, provided that no more than three (3) years have elapsed since the award of the
bonus to be reimbursed. Payment or reimbursement of amounts, as the case may be, including installments, payment dates, linkage
etc. would be specified by the Company's Compensation Committee and Board of Directors.

 

    	 	19	 

     

    

  

		11.	Term of the compensation policy

 

The compensation policy would be effective for a
3-year term starting on the approval date of the compensation policy by the General Meeting of Company shareholders.

 

		12.	Ratio of cost of terms of office and employment of
officers and those of other Company employees

 

		12.1.	The Company's Compensation Committee and Board of Directors
have reviewed the ratios of the terms of office and employment of officers and the cost of payroll5
of all other Company employees and of contractors hired by the Company6,
in particular the ratios to the average and median payroll of said employees, as of the approval date of this compensation policy
and have determined that these ratios should not impact labor relations at the Company, with reference, inter alia, to
how the Company operates, its size and the responsibility and job complexity of the various Company officers.

 

		12.2.	Below is the actual ratio as of the approval date of this compensation policy.

 

	Position	 	Ratio to average pay	 	Ratio to median pay
	Executive Chairman of Board of Directors(1)	 	
        Option 1 – 1.4

        Option 2 – 1.9
	 	
        Option 1 – 2.8

        Option 2 – 4.5

	Board members other than Executive Chairman of the Board or external / independent Board members7	 	-	 	-
	CEO	 	
        Option 1 – 13

        Option 2 – 15
	 	
        Option 1 – 25

        Option 2 – 32

	Other officer (other than Board member or CEO)	 	
        Option 1 – 4 – 5

        Option 2 – 4 – 6
	 	
        Option 1 – 8 – 11

        Option 2 – 9 – 14

 

 

 

		5	"Cost of payroll" – as defined in Addendum I to the
Corporate Act.

 

		6	Calculation of the aforementioned ratio only includes employees
of Itamar Medical Ltd.

 

		7	As of the approval date of this compensation policy, the
Company remunerates external Board members, independent Board members and the Executive Chairman of the Board of Directors.

 

    	 	20	 

     

    

  

		(1)	Assuming the current office of a Co-Chairman of the
Board of Directors represents a full-time position and assuming that securities awarded to them are similar to those for external
and independent Board members.

 

		(2)	In each of the categories in the table above, Option
1 is assuming 70% of maximum variable compensation and Option 2 is assuming the maximum variable compensation. For Board members,
Option 1 was calculated based on total compensation in 2015 and Option 2 includes option-based compensation.

 

		(3)	For ratio calculation, the numerator uses the officer
pay based on Option 1 or 2 - and the denominator uses payroll cost for all employees in 2015, except for officers (for which Option
1 or 2 is used as well); the denominator does not include the officer in question, nor does it include Board member compensation.

 

		(4)	Compensation for the Company CEO does not include
a stock option component with respect to relocation.

 

		(5)	The monthly payroll cost for option-based compensation
is calculated using the base salary plus social benefits.

 

		(6)	The data for this calculation is based on payroll
cost for 2015.

 

		(7)	The VP, Sales is eligible for both sales commissions
and bonuses.

 

		(8)	The calculation does
not include paid leave.

 

    	 	21	 

     

    

 

		13.	Miscellaneous

 

		13.1.	This document shall not confer any right on officers to whom this compensation policy applies, nor on any other third party,
to receive any compensation whatsoever.

 

		13.2.	Note, for the sake of clarification, that the content of this policy does not detract from provisions of the Corporate Act
and/or Company Bylaws with regard to the manner of approval of contracting between the Company and any officer with regard to their
terms of employment or office, and the provisions of this policy do not detract from any mandatory reporting with regard to officer
compensation pursuant to the Securities Act, 1968 and regulations based there upon.

 

		13.3.	The Company's Compensation Committee and Board of Directors shall specify the benchmarks composing the variable compensation
targets, based on the recommendation by Company management.

 

		13.4.	As part of the approval process of each annual plan, with its various components, by the Board of Directors, changes to Company
objectives, market conditions, the Company's position etc. would be reviewed annually. Consequently, and to the extent relevant,
the targets, benchmarks and compensation targets for each plan would be reviewed annually, and their actual application would be
subject to change based on decisions made by the Board of Directors from time to time.

 

		13.5.	The Board of Directors may, after approving a specific annual compensation plan, decide that no compensation would be paid
in conformity with this plan, and may order cancellation or suspension of the plan, in whole or in part, for reasons deemed appropriate
by the Board of Directors and due to considerations regarding the Company's best interest.

 

		13.6.	The Board of Directors would review from time to time the compensation policy and the need to revise it in case of any material
change in circumstances prevailing upon setting said policy, or for any other reasons.

 

		13.7.	If, after the approval date of this policy, provisions of the Corporate Act and/or regulations based there upon should be revised,
so as to be more lenient compared to provisions of this compensation policy, then such lenient provisions shall be considered to
be automatically adopted into the compensation policy (with no need for any further approval, including approval by the General
Meeting of shareholders) and these provisions shall prevail over the provisions of the compensation policy on the same matter.

 

*         *         *         *         *

 

    	 	22

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00290-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00290-of-00352.parquet"}]]